Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 3475
interventional 3156
Observational 285
Registry 34

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 1713
Biological 276
Biological|Drug 222
Drug|Other 116
Drug|Procedure 90
Biological|Drug|Other 84
Biological|Drug|Procedure|Radiation 68
Drug|Radiation 65
Biological|Drug|Procedure 54
Other 46
Drug|placebo 42
Biological|Drug|Radiation 41
Drug|Procedure|Radiation 40
Biological|Other 30
Procedure 30
Drug|Other|Procedure|Radiation 17
Biological|Drug|Other|Procedure|Radiation 16
Radiation 16
Drug|Other|Procedure 14
Biological|Drug|Other|Procedure 11
Behavioral 9
Biological|Other|Procedure 9
Biological|Procedure 8
Device 8
Dietary Supplement|Drug 8
Drug|Genetic 8
Biological|Radiation 7
Combination Product 6
Genetic 5
Biological|Drug|Genetic 4
Biological|Drug|Genetic|Other|Procedure 4
Biological|Drug|Other|Radiation 4
Device|Drug 4
Drug|Genetic|Other 4
Drug|Other|Radiation 4
Other|Procedure 4
Biological|Device|Drug 3
Biological|Drug|Genetic|Other 3
Biological|Procedure|Radiation 3
Combination Product|Drug 3
Dietary Supplement 3
Dietary Supplement|Other 3
Drug|Genetic|Other|Procedure|Radiation 3
Behavioral|Drug 2
Behavioral|Other 2
Biological|Drug|placebo 2
Biological|Other|placebo 2
Biological|Other|Radiation 2
Biological|placebo 2
Device|Drug|Procedure 2
Device|Other 2
Diagnostic Test 2
Diagnostic Test|Drug|Procedure 2
Drug|Other|placebo|Procedure 2
Genetic|Procedure 2
Other|Radiation 2
Procedure|Radiation 2
Behavioral|Dietary Supplement|Other|Procedure 1
Biological|Device|Drug|Other|Procedure 1
Biological|Device|Drug|Procedure|Radiation 1
Biological|Dietary Supplement|Drug|Other|placebo 1
Biological|Dietary Supplement|Drug|placebo 1
Biological|Dietary Supplement|placebo 1
Biological|Drug|Other|placebo 1
Biological|Genetic|Other 1
Biological|Genetic|Other|Procedure 1
Combination Product|Drug|placebo 1
Device|Drug|Procedure|Radiation 1
Device|Procedure 1
Diagnostic Test|Drug|Genetic|Procedure|Radiation 1
Dietary Supplement|Drug|Other 1
Dietary Supplement|Other|placebo 1
Drug|Genetic|Other|Procedure 1
Drug|Genetic|Procedure 1
Drug|Genetic|Procedure|Radiation 1
Drug|Other|placebo 1
Drug|placebo|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 1687
China 235
NA 88
France 75
Germany 66
Korea, Republic of 54
United States|Canada 54
Italy 52
Japan 51
United Kingdom 46
Canada 41
Spain 28
Belgium|France 19
United States|Puerto Rico 18
Australia 15
Switzerland 15
United States|United Kingdom 13
Israel 12
Taiwan 12
United States|Australia|Canada 12
United States|France 11
Russian Federation 10
Austria 7
Singapore 7
United States|Australia 7
United States|Germany 7
United States|Italy 7
Netherlands 6
Norway 6
United States|Germany|Italy 6
Denmark 5
France|United Kingdom 5
Denmark|Finland|Norway|Sweden 4
Germany|Switzerland 4
Hong Kong 4
Poland 4
United States|Canada|Puerto Rico 4
United States|France|United Kingdom 4
United States|Spain 4
Belgium|France|Switzerland 3
France|Germany 3
India 3
Italy|Switzerland 3
Japan|Korea, Republic of 3
Thailand 3
United States|Australia|Canada|Puerto Rico|Switzerland 3
United States|Canada|France|Netherlands 3
United States|Israel 3
United States|Japan 3
Australia|United Kingdom 2
Belgium|Netherlands 2
Czech Republic 2
France|Italy 2
France|Italy|Switzerland 2
Germany|United Kingdom 2
Hungary 2
Mexico 2
Saudi Arabia 2
Sweden 2
United States|Australia|Austria|Belgium|France|Germany|Hungary|Italy|New Zealand|Spain|United Kingdom 2
United States|Australia|Belgium|Canada|China|Czechia|Ireland|Israel|Italy|New Zealand|Poland|Russian Federation|Spain|Turkey|Ukraine|United Kingdom 2
United States|Australia|Canada|Netherlands|New Zealand|Puerto Rico|Switzerland 2
United States|Australia|Italy 2
United States|Belgium|Canada|Spain 2
United States|Denmark|Germany 2
United States|France|Germany 2
United States|France|Spain 2
United States|France|Spain|United Kingdom 2
United States|Italy|Poland|Spain 2
United States|Italy|Spain|United Kingdom 2
United States|Korea, Republic of 2
United States|Netherlands 2
United States|Switzerland 2
Albania|Argentina|Australia|Bosnia and Herzegovina|Brazil|Bulgaria|Colombia|Croatia|Ecuador|Egypt|Finland|Germany|Greece|Israel|Italy|Mexico|Romania|Russian Federation|Slovakia|Slovenia|Spain|Sweden|Switzerland|Turkey 1
Albania|Argentina|Austria|Brazil|Bulgaria|Colombia|Ecuador|Egypt|France|Germany|Greece|Hungary|Italy|Lithuania|Norway|Romania|Russian Federation|Slovakia|Slovenia|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
Algeria|Argentina|Belgium|Brazil|Bulgaria|Canada|Colombia|Finland|France|Greece|Ireland|Israel|Italy|Netherlands|Peru|Poland|Portugal|Russian Federation|Saudi Arabia|Serbia|South Africa|Spain|Thailand|Turkey|Ukraine|United Kingdom|Venezuela 1
Argentina 1
Argentina|Australia|Austria|Brazil|Bulgaria|Colombia|France|Germany|Greece|Hungary|India|Ireland|Israel|Italy|Japan|Malaysia|Netherlands|Peru|Poland|Portugal|Romania|Russian Federation|South Africa|Spain|Ukraine|United Kingdom 1
Argentina|Australia|Belgium|Brazil|Colombia|Denmark|France|Netherlands|New Zealand|Peru|Spain|Thailand 1
Argentina|Australia|Brazil|Canada|Czech Republic|Denmark|Ecuador|Finland|France|Israel|Italy|Korea, Republic of|Mexico|Norway|Peru|Poland|Russian Federation|Slovakia|Spain|Sweden|Switzerland|United Kingdom 1
Argentina|Brazil|Colombia|India|Indonesia|Iran, Islamic Republic of|Malaysia|Mexico|Paraguay|Philippines|Russian Federation|South Africa 1
Australia|Austria|Belgium|Croatia|Czechia|France|Germany|Greece|Hungary|New Zealand|Poland|Russian Federation|Spain 1
Australia|Austria|Belgium|Czechia|Denmark|France|Germany|Ireland|Israel|Italy|Netherlands|New Zealand|Norway|Poland|Slovakia|Spain|Sweden|Switzerland|United Kingdom 1
Australia|Austria|Belgium|France|Israel|Poland|Portugal|Spain|Switzerland 1
Australia|Austria|Bosnia and Herzegovina|Brazil|Bulgaria|China|Croatia|Czech Republic|Estonia|Hong Kong|Israel|Latvia|Macedonia, The Former Yugoslav Republic of|Malaysia|Mexico|Peru|Romania|Russian Federation|Serbia|Slovakia|Slovenia|South Africa|Sweden|Taiwan|Thailand|Turkey 1
Australia|Belgium|Bosnia and Herzegovina|Brazil|Bulgaria|Canada|Colombia|Croatia|Denmark|Finland|France|Georgia|Germany|Greece|Italy|Macedonia, The Former Yugoslav Republic of|Malaysia|Mexico|New Zealand|Peru|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Thailand|Turkey|United Kingdom 1
Australia|Belgium|Canada|Denmark|France|Germany|Italy|Korea, Republic of|Singapore|United Kingdom 1
Australia|Belgium|Canada|France|Germany|Italy|Portugal|Spain 1
Australia|Belgium|Denmark|Italy|Spain 1
Australia|Canada|France|Italy|Sweden|Switzerland 1
Australia|Canada|New Zealand 1
Australia|France|Germany|Hungary|Korea, Republic of|Poland|Singapore|United Kingdom 1
Australia|France|Germany|Italy|Spain|United Kingdom 1
Australia|France|Germany|Netherlands 1
Australia|France|Spain|United Kingdom 1
Australia|New Zealand 1
Australia|New Zealand|Poland|Russian Federation|Thailand 1
Australia|New Zealand|United Kingdom 1
Australia|United States|Belgium|Canada|China|Czechia|France|Ireland|Israel|Italy|Japan|Korea, Republic of|Netherlands|New Zealand|Poland|Portugal|Puerto Rico|Russian Federation|Spain|Switzerland|Taiwan|Turkey 1
Austria|Belgium|China|Czechia|Denmark|Finland|France|Germany|Hungary|Ireland|Israel|Italy|Netherlands|Norway|Poland|Portugal|Russian Federation|Slovakia|Spain|Sweden|Switzerland 1
Austria|Belgium|Czechia|Denmark|Finland|Germany|Netherlands|Norway|Poland|Portugal|Sweden 1
Austria|Belgium|Finland|France|Germany|Italy|Japan|Netherlands|Spain|Switzerland|United Kingdom 1
Austria|Belgium|France|Germany|Israel|Netherlands|Poland|Portugal 1
Austria|Czechia|Denmark|Finland|Germany|Norway|Sweden|Switzerland 1
Austria|Denmark|Finland|Norway|Sweden|Switzerland 1
Austria|France|Germany|Switzerland 1
Austria|France|Norway 1
Austria|Germany 1
Austria|Germany|Israel|Italy|Switzerland|United Kingdom 1
Austria|Italy|Spain 1
Austria|Italy|Switzerland 1
Austria|Switzerland 1
Belgium 1
Belgium|Brazil|Canada|Chile|Colombia|Czechia|France|Germany|Hungary|Ireland|Korea, Republic of|Mexico|Netherlands|Poland|Portugal|Russian Federation|Spain|Sweden|Taiwan|Ukraine|United Kingdom 1
Belgium|Brazil|United States|Australia|Canada|Czechia|Hungary|Korea, Republic of|Mexico|New Zealand|Poland|Puerto Rico|Russian Federation 1
Belgium|Canada|China|France|Hungary|Italy|Netherlands|Poland|Spain|United Kingdom 1
Belgium|Canada|Czech Republic|Finland|France|Germany|United States|Greece|Israel|Slovakia|Switzerland|Turkey|United Kingdom 1
Belgium|Canada|Denmark|France|Germany|Italy|Netherlands|Norway|Portugal|Spain|Sweden|Switzerland|United Kingdom 1
Belgium|Canada|United States|Australia|France|Germany|Italy|Netherlands|Singapore|Spain|Sweden|United Kingdom 1
Belgium|Croatia|Czech Republic|France|Germany|Italy|Netherlands|Portugal|Slovakia|Turkey 1
Belgium|Croatia|Czechia|Hungary|Poland|Portugal|Romania|Spain|Turkey|United Kingdom 1
Belgium|Croatia|Denmark|Egypt|Netherlands|Poland|Portugal|Slovakia|Spain 1
Belgium|Croatia|Egypt|France|Netherlands 1
Belgium|Czechia|Denmark|France|Germany|Greece|Israel|Italy|Netherlands|Poland|Russian Federation|Spain|Sweden|United Kingdom 1
Belgium|Denmark|Italy|Spain|United Kingdom 1
Belgium|Egypt|France|Netherlands|Portugal|Switzerland|United Kingdom 1
Belgium|France|Germany|Italy|Korea, Republic of|Portugal|Singapore|Spain 1
Belgium|France|Germany|Netherlands|Poland|Portugal|Spain 1
Belgium|France|Italy 1
Belgium|France|Italy|Portugal|Switzerland 1
Belgium|France|Italy|Spain|Switzerland|United Kingdom 1
Belgium|France|Netherlands 1
Belgium|France|United Kingdom 1
Belgium|Italy|Spain 1
Belgium|Lithuania|Spain 1
Bosnia and Herzegovina|Croatia|Georgia|Moldova, Republic of|Poland|Serbia|Ukraine 1
Brazil|Bulgaria|China|Greece|Italy|Korea, Republic of|Poland|Portugal|Russian Federation|South Africa|Taiwan|Turkey 1
Brazil|Italy|North Macedonia|Serbia|Slovakia|South Africa|Switzerland 1
Brazil|United States|Argentina|Austria|Belgium|Canada|Croatia|Denmark|Greece|Italy|Netherlands|Poland|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
Canada|Italy|United Kingdom 1
Canada|United States 1
Canada|United States|Australia|New Zealand|Switzerland 1
Chile|Italy|Spain|Switzerland 1
China|Hong Kong|Korea, Republic of|Singapore|Taiwan 1
China|Korea, Republic of|Thailand 1
China|Malaysia|Australia|Taiwan 1
Colombia|India|Russian Federation|South Africa|Ukraine 1
Colombia|Mexico 1
Czech Republic|France|Germany|Italy|Netherlands|Poland|Sweden|Switzerland|United Kingdom 1
Czech Republic|Poland|Romania 1
Czechia|Germany|Malaysia|Poland|Spain|Thailand|Turkey 1
Czechia|Italy|Netherlands|United Kingdom 1
Czechia|Norway|Poland|United Kingdom 1
Denmark|Finland|Italy|Switzerland 1
Denmark|Finland|Netherlands|Norway|Sweden 1
Denmark|Finland|Norway 1
Denmark|France|Italy|Netherlands|Spain|United Kingdom 1
Denmark|Germany|Italy|Norway|Sweden 1
Denmark|Netherlands|Spain|United Kingdom 1
Denmark|Norway|Sweden 1
Denmark|Sweden 1
Egypt 1
Finland 1
France|Belgium 1
France|Germany|Korea, Republic of 1
France|Germany|Russian Federation 1
France|Italy|Japan|Spain 1
France|Italy|Korea, Republic of|Netherlands|Portugal|Spain|Taiwan 1
France|Italy|Netherlands 1
France|Italy|Peru|Puerto Rico|Spain|Switzerland 1
France|Italy|Poland|Taiwan|Ukraine|Germany|United States|Australia|Canada|United Kingdom 1
France|Italy|Spain|United Kingdom 1
France|Spain 1
France|United States|Australia|Belgium|Denmark|Germany|Israel|Italy|Poland|Spain|United Kingdom 1
France|United States|Belgium|Czechia|Denmark|Germany|Israel|Italy|Poland|Spain|United Kingdom 1
France|United States|Belgium|Germany|United Kingdom 1
Germany|Israel 1
Germany|Israel|Italy 1
Germany|Italy|Spain 1
Germany|Italy|Switzerland 1
Germany|Italy|Switzerland|United Kingdom 1
Germany|Netherlands|United Kingdom 1
Germany|United States|Belgium|France|Spain|Switzerland|United Kingdom 1
Hong Kong|Japan|Korea, Republic of|Taiwan 1
Hungary|Argentina|Australia|Austria|Brazil|Canada|Chile|Colombia|Croatia|Denmark|Dominican Republic|Egypt|El Salvador|Germany|Guatemala|Hong Kong|Indonesia|Italy|Korea, Republic of|Malaysia|Netherlands|New Zealand|Panama|Peru|Philippines|Portugal|Romania|Sweden|Taiwan|Thailand|Turkey|Vietnam 1
Italy|Poland|United Kingdom 1
Italy|United States|Czechia|Japan|Korea, Republic of|Singapore 1
Japan|United Kingdom 1
Japan|United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Chile|China|Colombia|France|Germany|Greece|Hong Kong|Hungary|Ireland|Italy|Korea, Republic of|Lithuania|Malaysia|Mexico|New Zealand|Philippines|Poland|Portugal|Romania|Russian Federation|Singapore|Slovakia|South Africa|Spain|Taiwan|Thailand|Turkey|Ukraine|Vietnam 1
Japan|United States|Argentina|Australia|Belgium|Brazil|Canada|China|Czechia|France|Germany|Greece|Hong Kong|Hungary|Israel|Italy|Korea, Republic of|Mexico|New Zealand|Peru|Poland|Russian Federation|Spain|Taiwan|Ukraine|Vietnam 1
Japan|United States|Argentina|Australia|Belgium|Brazil|China|France|Germany|Israel|Korea, Republic of|Poland|Puerto Rico|Russian Federation|Spain|Sweden|Turkey|Ukraine|United Kingdom 1
Japan|United States|Argentina|Austria|Belgium|China|Czech Republic|Denmark|Estonia|Finland|Germany|Greece|Hungary|India|Ireland|Israel|Korea, Republic of|Netherlands|Norway|Poland|Russian Federation|Singapore|Spain|Sweden|Thailand|United Kingdom 1
Kenya|Zimbabwe 1
Korea, Republic of|Malaysia|Singapore 1
Korea, Republic of|Singapore 1
Malawi 1
Netherlands|Australia|Belgium|Canada|Denmark|Egypt|France|Hungary|Italy|New Zealand|Norway|Poland|Portugal|Slovakia|Slovenia|South Africa|Sweden|United Kingdom 1
Netherlands|Belgium|Croatia|Denmark|France 1
Netherlands|United Kingdom 1
New Zealand 1
New Zealand|Australia|Austria|Belgium|Canada|Czech Republic|Denmark|France|Germany|Israel|Poland|Portugal|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
Norway|Sweden|Switzerland 1
Poland|United States|Australia|Belgium|Brazil|Canada|Czechia|Denmark|France|Hong Kong|Hungary|Italy|Japan|Korea, Republic of|Norway|Russian Federation|South Africa|Spain|Taiwan|Turkey|United Kingdom 1
Puerto Rico 1
Serbia 1
Spain|France|Germany|Italy|Netherlands|Sweden|United Kingdom 1
Spain|Slovakia|United States|Argentina|Australia|Belgium|Brazil|Canada|China|Czechia|France|Germany|Greece|Hungary|Ireland|Israel|Japan|Korea, Republic of|Mexico|Netherlands|Poland|Puerto Rico|Russian Federation|Sweden|Taiwan|Turkey|Ukraine|United Kingdom 1
Spain|Switzerland 1
Spain|United States|Australia|Bulgaria|Canada|Colombia|Czechia|France|Georgia|Germany|Greece|India|Israel|Italy|Japan|Korea, Republic of|Mexico|Poland|Romania|Ukraine 1
Spain|United States|Belgium|Germany|Hungary|Italy|Poland 1
Spain|United States|France 1
Sweden|Denmark|Finland|Norway 1
Sweden|United Kingdom 1
Switzerland|Austria|Germany|Greece|Italy 1
Switzerland|United Kingdom 1
Taiwan|Spain|United States|Poland|United Kingdom 1
Turkey 1
Turkey|Ukraine|Brazil|United States|Argentina|Australia|Belgium|Canada|China|Czechia|Denmark|Finland|France|Germany|Hungary|Israel|Japan|Korea, Republic of|Mexico|Netherlands|Norway|Poland|Russian Federation|Spain|Sweden|Taiwan|United Kingdom 1
United Kingdom|Australia 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|China|France|Germany|Italy|Netherlands|Poland|Spain|Sweden|Switzerland|United Kingdom 1
United States|Argentina|Australia|Austria|Brazil|Canada|China|Colombia|Czechia|Egypt|France|Germany|Greece|Hong Kong|Hungary|Israel|Italy|Japan|Korea, Republic of|Lebanon|Mexico|New Zealand|Norway|Peru|Poland|Russian Federation|Saudi Arabia|Singapore|Slovakia|Spain|Switzerland|Thailand|Turkey|Venezuela 1
United States|Argentina|Australia|Belgium|Brazil|Canada|China|Colombia|Czechia|France|Germany|Greece|Hungary|Ireland|Israel|Italy|Korea, Republic of|Mexico|Netherlands|Poland|Portugal|Russian Federation|Spain|Sweden|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|China|Cyprus|Czech Republic|Finland|France|Germany|Greece|Hungary|India|Israel|Italy|Korea, Republic of|Mexico|New Zealand|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Slovakia|South Africa|Spain|Sweden|Thailand|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Canada|Finland|France|Germany|Hungary|Italy|Spain|Switzerland 1
United States|Argentina|Belgium|Brazil|Canada|Colombia|Czechia|France|Germany|Greece|Israel|Korea, Republic of|Mexico|Poland|Portugal|Russian Federation|Spain|Sweden|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Bulgaria|Costa Rica|Ecuador|Estonia|France|Germany|Hungary|India|Italy|Mexico|Panama|Peru|Poland|Romania|Russian Federation|Ukraine|United Kingdom|Uruguay 1
United States|Argentina|Canada|China|Czechia|Germany|Italy|Norway|Poland|Portugal|Sweden|Switzerland|Ukraine|United Kingdom 1
United States|Argentina|Mexico 1
United States|Australia|Austria|Belarus|Belgium|Brazil|Bulgaria|Canada|Chile|Czechia|Denmark|Egypt|France|Germany|Hungary|Israel|Italy|Mexico|Netherlands|New Zealand|Peru|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Slovakia|Spain|Sweden|Turkey|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Canada|China|Czechia|France|Germany|Hong Kong|Israel|Italy|Japan|Korea, Republic of|New Zealand|Poland|Russian Federation|Spain|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|France|Germany|Italy|Poland|Spain|Switzerland|United Kingdom 1
United States|Australia|Austria|Belgium|Bulgaria|Canada|Finland|France|Germany|Greece|Hong Kong|Hungary|Ireland|Israel|Italy|Korea, Republic of|New Zealand|Poland|Portugal|Russian Federation|Singapore|Spain|Sweden|Turkey|United Kingdom 1
United States|Australia|Austria|Belgium|Bulgaria|Canada|France|Germany|Greece|Hungary|India|Israel|Italy|Netherlands|New Zealand|Poland|Serbia|Spain|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Croatia|Czechia|Denmark|Finland|France|Hungary|Ireland|Israel|Italy|Korea, Republic of|Netherlands|Norway|Poland|Singapore|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Czechia|France|Greece|Hungary|Israel|Italy|Netherlands|New Zealand|Poland|Portugal|Russian Federation|Spain|Taiwan|Turkey|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Czechia|France|Israel|Italy|New Zealand|Poland|Russian Federation|Spain|Sweden|Turkey|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|France|Germany|Israel|Italy|Netherlands|Spain|Sweden|Switzerland|United Kingdom 1
United States|Australia|Austria|Belgium|China|France|New Zealand|Poland|Spain|Taiwan 1
United States|Australia|Austria|Belgium|Czechia|France|Germany|Italy|Japan|Netherlands|Singapore|Spain|Switzerland|Taiwan 1
United States|Australia|Austria|Belgium|Czechia|France|Italy|New Zealand|Poland|Russian Federation|Spain|Sweden|Taiwan|United Kingdom 1
United States|Australia|Austria|Belgium|France|Germany|Italy|Japan|Netherlands|Norway|Spain|United Kingdom 1
United States|Australia|Austria|Belgium|France|Germany|Italy|Korea, Republic of|New Zealand|Poland|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Austria|Belgium|France|Ireland|Italy|Poland|Spain|United Kingdom 1
United States|Australia|Austria|Canada|Croatia|Czechia|Finland|France|Germany|Hungary|Israel|Italy|Korea, Republic of|New Zealand|Poland|Portugal|Romania|Serbia|Singapore|Spain|Taiwan|Turkey|United Kingdom 1
United States|Australia|Austria|Canada|Czechia|France|Hungary|Italy|Netherlands|Spain 1
United States|Australia|Austria|Canada|Denmark|Finland|France|Italy|Japan|Netherlands|Norway|Spain 1
United States|Australia|Austria|Canada|France|Germany|Italy|Japan|Netherlands|Norway 1
United States|Australia|Austria|Canada|Germany|Netherlands|Poland|Russian Federation|Switzerland|United Kingdom 1
United States|Australia|Austria|Canada|Germany|Poland|Russian Federation|Switzerland|United Kingdom 1
United States|Australia|Austria|Czechia|France|Italy|Spain|Sweden|United Kingdom 1
United States|Australia|Austria|Finland|France|Germany|Italy|Spain|Switzerland|United Kingdom 1
United States|Australia|Austria|France|Germany|Hong Kong|Italy|Japan|Netherlands|Norway|Singapore|Spain|Switzerland 1
United States|Australia|Belarus|Bulgaria|Canada|China|Czechia|France|Germany|Italy|Korea, Republic of|New Zealand|Poland|Russian Federation|Spain|Taiwan|United Kingdom 1
United States|Australia|Belgium|Brazil|Bulgaria|Canada|Chile|China|Czechia|Denmark|Finland|France|Germany|Greece|Hong Kong|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Mexico|Poland|Portugal|Romania|Russian Federation|Singapore|Slovakia|South Africa|Spain|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Australia|Belgium|Brazil|Canada|China|Czechia|Denmark|Finland|France|Germany|Greece|Hungary|India|Italy|Japan|Korea, Republic of|Mexico|Poland|Portugal|Puerto Rico|Spain|Sweden|Taiwan|United Kingdom 1
United States|Australia|Belgium|Brazil|Canada|France|Germany|Israel|Italy|Netherlands|New Zealand|Poland|Russian Federation|Singapore 1
United States|Australia|Belgium|Brazil|France|Germany|Israel|Italy|Malaysia|New Zealand|Singapore|Spain|United Kingdom 1
United States|Australia|Belgium|Canada|China|Czechia|Finland|France|Germany|Hungary|Israel|Italy|Japan|Russian Federation|Spain|Sweden|Taiwan|United Kingdom 1
United States|Australia|Belgium|Canada|Czechia|Denmark|Finland|France|Italy|New Zealand|Poland|Spain|Taiwan 1
United States|Australia|Belgium|Canada|Czechia|France|Germany|Greece|Hungary|Italy|Korea, Republic of|Netherlands|Poland|Spain|Turkey|Ukraine|United Kingdom 1
United States|Australia|Belgium|Canada|Czechia|France|Greece|Israel|Italy|New Zealand|Poland|Russian Federation|Spain|Sweden|Turkey 1
United States|Australia|Belgium|Canada|Czechia|France|Italy|Korea, Republic of|Poland|Spain|United Kingdom 1
United States|Australia|Belgium|Canada|France|Germany|Hong Kong|Italy|Korea, Republic of|Singapore|United Kingdom 1
United States|Australia|Belgium|Canada|France|Germany|Italy|Norway|Singapore|Spain|Sweden|United Kingdom 1
United States|Australia|Belgium|Canada|France|Germany|Italy|United Kingdom 1
United States|Australia|Belgium|Canada|France|Italy|Spain 1
United States|Australia|Belgium|Canada|France|Italy|Spain|United Kingdom 1
United States|Australia|Belgium|Canada|Germany|New Zealand|Sweden|Turkey|United Kingdom 1
United States|Australia|Belgium|Canada|Italy|Puerto Rico|Spain|United Kingdom 1
United States|Australia|Belgium|China|Czechia|France|Germany|Italy|Netherlands|New Zealand|Poland|Spain|Sweden|Turkey|United Kingdom 1
United States|Australia|Belgium|Czechia|Finland|Germany|Israel|Sweden|Switzerland|United Kingdom 1
United States|Australia|Belgium|France|Germany|Hong Kong|Italy|Korea, Republic of|Netherlands|Poland|Spain|Switzerland|United Kingdom 1
United States|Australia|Belgium|France|Germany|Netherlands 1
United States|Australia|Belgium|France|Germany|Poland|Russian Federation|Spain|United Kingdom 1
United States|Australia|Belgium|Italy|Korea, Republic of|Poland|Spain|United Kingdom 1
United States|Australia|Brazil|Canada|Mexico|New Zealand|Peru 1
United States|Australia|Brazil|France|Germany|Israel|Italy|Korea, Republic of|New Zealand|Sweden|United Kingdom 1
United States|Australia|Brazil|India|Mexico|Peru 1
United States|Australia|Canada|Czechia|Denmark|France|Germany|Hungary|Israel|Italy|Korea, Republic of|Poland|Romania|Spain|Taiwan|United Kingdom 1
United States|Australia|Canada|Czechia|Denmark|Germany|Hungary|Israel|Italy|Poland|Spain|Sweden|United Kingdom 1
United States|Australia|Canada|Czechia|France|Germany|Hungary|Italy|Korea, Republic of|Netherlands|Spain|Turkey|United Kingdom 1
United States|Australia|Canada|Czechia|France|Israel|Italy|Poland|Romania|Spain|United Kingdom 1
United States|Australia|Canada|Denmark|France|Germany|Italy|Spain|United Kingdom 1
United States|Australia|Canada|France 1
United States|Australia|Canada|France|Germany|Italy|Korea, Republic of|Netherlands|Spain|United Kingdom 1
United States|Australia|Canada|France|Germany|Korea, Republic of|Spain|United Kingdom 1
United States|Australia|Canada|France|Italy|Korea, Republic of|Poland|Singapore|Spain|Taiwan|United Kingdom 1
United States|Australia|Canada|Germany|Israel|Italy 1
United States|Australia|Canada|Germany|Japan|Netherlands|Spain|Switzerland 1
United States|Australia|Canada|Ireland|New Zealand|Puerto Rico|Switzerland 1
United States|Australia|Canada|Israel 1
United States|Australia|Canada|Israel|New Zealand|Puerto Rico|Switzerland 1
United States|Australia|Canada|Netherlands|Puerto Rico|Switzerland 1
United States|Australia|Canada|New Zealand 1
United States|Australia|Canada|New Zealand|Puerto Rico 1
United States|Australia|Canada|New Zealand|Saudi Arabia 1
United States|Australia|Canada|Puerto Rico 1
United States|Australia|Chile|Czechia|France|Germany|Hungary|Italy|Korea, Republic of|Mexico|South Africa|Spain|Turkey|United Kingdom 1
United States|Australia|China|Czechia|France|Italy|Korea, Republic of|New Zealand|United Kingdom 1
United States|Australia|Czechia|France|Germany|Italy|Korea, Republic of|Poland|Romania|Russian Federation|Serbia 1
United States|Australia|Czechia|France|Germany|Poland|Spain|Sweden|Ukraine|United Kingdom 1
United States|Australia|Denmark|France|Germany|Italy|Japan|Netherlands|Spain|Switzerland|United Kingdom 1
United States|Australia|Denmark|Spain 1
United States|Australia|France|Germany|Israel|Korea, Republic of|Spain 1
United States|Australia|France|Germany|Italy 1
United States|Australia|France|Germany|Italy|Japan|Spain 1
United States|Australia|France|Germany|Netherlands|Spain 1
United States|Australia|France|Greece|Hong Kong|Poland|Russian Federation|Singapore 1
United States|Australia|France|Italy|Japan 1
United States|Australia|France|Italy|Korea, Republic of|Poland|Russian Federation|Spain|Turkey 1
United States|Australia|France|Poland 1
United States|Australia|France|Poland|United Kingdom 1
United States|Australia|Germany 1
United States|Australia|Israel|Italy|Korea, Republic of|Poland|Slovakia|Spain|United Kingdom 1
United States|Australia|Italy|New Zealand|Spain 1
United States|Australia|Korea, Republic of 1
United States|Australia|Peru|Puerto Rico|South Africa 1
United States|Australia|Puerto Rico 1
United States|Austria|Belarus|Belgium|Brazil|Croatia|France|Georgia|Germany|Greece|India|Italy|Japan|Korea, Republic of|Lebanon|Mexico|Peru|Philippines|Poland|Portugal|Puerto Rico|Romania|Russian Federation|South Africa|Spain|Switzerland|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Austria|Belgium|Brazil|Canada|Chile|China|Colombia|Czechia|Germany|Hungary|India|Israel|Italy|Malaysia|Morocco|Philippines|Poland|Portugal|Romania|Russian Federation|Singapore|South Africa|Spain|Taiwan|Thailand|Tunisia|Turkey|Ukraine 1
United States|Austria|Belgium|Bulgaria|Czechia|Denmark|France|Germany|Hungary|Italy|Poland|Romania|Russian Federation|Slovakia|Spain|Ukraine|United Kingdom 1
United States|Austria|Belgium|Canada|Czechia|France|Germany|Italy|Netherlands|Russian Federation|Spain|Sweden|Switzerland|United Kingdom 1
United States|Austria|Belgium|Colombia|France|Germany|Hungary|Israel|Italy|Puerto Rico|Singapore|Spain|Turkey|United Kingdom 1
United States|Austria|Belgium|Czechia|Germany|Portugal 1
United States|Austria|Canada|Germany 1
United States|Austria|Czech Republic|France|Germany|Lithuania|Romania|Russian Federation|Sweden|Turkey|United Kingdom 1
United States|Austria|Denmark|Estonia|United Kingdom 1
United States|Austria|France|Germany 1
United States|Austria|Germany|Italy|Spain 1
United States|Austria|Korea, Republic of|Spain 1
United States|Belarus|Belgium|Bulgaria|Canada|Czechia|France|Georgia|Hungary|Italy|Spain|United Kingdom 1
United States|Belgium|Brazil|Bulgaria|Canada|Czechia|France|Germany|Hungary|Italy|Korea, Republic of|Netherlands|Poland|Romania|Russian Federation|Spain|Sweden|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Belgium|Brazil|China|Czechia|France|Germany|Israel|Italy|Japan|Poland|Portugal|Puerto Rico|Russian Federation|Spain|Turkey|United Kingdom 1
United States|Belgium|Brazil|France|Peru|United Kingdom 1
United States|Belgium|Bulgaria|Czechia|Hungary|Italy|Poland|Switzerland|Ukraine 1
United States|Belgium|Canada|Croatia|Denmark|France|Germany|Hungary|Israel|Italy|Netherlands|Poland|Russian Federation|Slovakia|South Africa|Spain|United Kingdom 1
United States|Belgium|Canada|Denmark|Korea, Republic of 1
United States|Belgium|Canada|France|Hong Kong|Japan|Korea, Republic of|Singapore|United Kingdom 1
United States|Belgium|Canada|France|Italy 1
United States|Belgium|Canada|France|Italy|Spain|United Kingdom 1
United States|Belgium|Canada|France|Italy|United Kingdom 1
United States|Belgium|Canada|France|United Kingdom 1
United States|Belgium|Canada|Germany|Korea, Republic of 1
United States|Belgium|Canada|United Kingdom 1
United States|Belgium|Czechia|France|Germany|Hungary|Italy|Poland|Spain|United Kingdom 1
United States|Belgium|Czechia|Israel|Italy|Poland|Spain|Turkey|United Kingdom 1
United States|Belgium|France|Germany|Israel|Italy|Netherlands|Spain|Sweden|United Kingdom 1
United States|Belgium|France|Germany|Italy|Japan|Netherlands|Spain|Sweden|Switzerland|United Kingdom 1
United States|Belgium|France|Germany|Italy|Korea, Republic of|Spain|Turkey 1
United States|Belgium|France|Greece|Italy|Poland 1
United States|Belgium|France|Israel|Poland|Puerto Rico|Russian Federation|Spain|United Kingdom 1
United States|Belgium|France|Italy 1
United States|Belgium|France|Italy|Netherlands|Spain 1
United States|Belgium|France|Italy|Spain 1
United States|Belgium|France|Italy|Spain|United Kingdom 1
United States|Belgium|Germany|Hong Kong|Hungary|Japan|Korea, Republic of|Netherlands|Singapore 1
United States|Belgium|Germany|United Kingdom 1
United States|Belgium|Israel 1
United States|Belgium|United Kingdom 1
United States|Bosnia and Herzegovina|France|Israel|Serbia|United Kingdom 1
United States|Brazil|Canada|Czechia|France|Germany|Hong Kong|Hungary|Israel|Italy|Japan|Russian Federation|Singapore 1
United States|Brazil|Chile 1
United States|Brazil|France|Israel|Italy|Netherlands|Portugal|Singapore|Spain|United Kingdom 1
United States|Brazil|Germany|Japan|Netherlands|Spain|United Kingdom 1
United States|Brazil|Hong Kong|Italy|Japan|Singapore|Taiwan 1
United States|Bulgaria|Czechia|France|Germany|Hungary|Italy|Poland|Romania|Russian Federation|Serbia|Spain|United Kingdom 1
United States|Canada|China|France|Germany|Hong Kong|Italy|Taiwan 1
United States|Canada|China|France|Germany|Japan|Singapore|Switzerland|United Kingdom 1
United States|Canada|Czechia|France|Germany|Hungary|Israel|Poland|Russian Federation|Spain|Turkey 1
United States|Canada|France|Germany|Israel|Netherlands 1
United States|Canada|France|Germany|Italy 1
United States|Canada|France|Germany|Italy|Netherlands 1
United States|Canada|France|Germany|Italy|Spain|United Kingdom 1
United States|Canada|France|Germany|Netherlands|United Kingdom 1
United States|Canada|France|Germany|Spain|United Kingdom 1
United States|Canada|France|Italy 1
United States|Canada|France|Italy|Poland 1
United States|Canada|France|Italy|Spain 1
United States|Canada|France|Spain 1
United States|Canada|France|United Kingdom 1
United States|Canada|Georgia|Moldova, Republic of|Poland|Spain|Ukraine 1
United States|Canada|Germany 1
United States|Canada|Israel|Japan|Singapore|Spain 1
United States|Canada|Korea, Republic of|Taiwan 1
United States|Canada|Puerto Rico|Switzerland 1
United States|Canada|Singapore 1
United States|Canada|South Africa 1
United States|Canada|Sweden|United Kingdom 1
United States|Canada|Switzerland 1
United States|China 1
United States|China|Italy|Japan|Korea, Republic of|Russian Federation|Taiwan 1
United States|China|Japan|Singapore 1
United States|Colombia|Czechia|France|Germany|Guatemala|Italy|Korea, Republic of|Spain 1
United States|Czechia|Denmark|Hungary|Italy|Spain 1
United States|Czechia|Italy|Korea, Republic of|Poland|Russian Federation 1
United States|Denmark 1
United States|Denmark|Italy 1
United States|Denmark|United Kingdom 1
United States|Egypt|India 1
United States|Egypt|Singapore 1
United States|Finland|France|Netherlands|Spain 1
United States|France|Germany|Hong Kong|Italy|Korea, Republic of|Netherlands|Taiwan 1
United States|France|Germany|Italy 1
United States|France|Germany|Italy|Japan|Netherlands|United Kingdom 1
United States|France|Germany|Italy|Mexico|Netherlands|Spain|United Kingdom 1
United States|France|Germany|Italy|Poland|United Kingdom 1
United States|France|Germany|Italy|Spain|United Kingdom 1
United States|France|Germany|Italy|United Kingdom 1
United States|France|Germany|Korea, Republic of|Singapore|United Kingdom 1
United States|France|Germany|Netherlands 1
United States|France|Germany|Poland|Russian Federation|United Kingdom 1
United States|France|Germany|Portugal|Spain|United Kingdom 1
United States|France|Germany|Spain 1
United States|France|Hong Kong|Italy|Korea, Republic of|Poland|Russian Federation|Spain|Turkey 1
United States|France|Ireland|United Kingdom 1
United States|France|Israel|Korea, Republic of|United Kingdom 1
United States|France|Italy|Netherlands|Spain|Switzerland 1
United States|France|Netherlands 1
United States|France|Netherlands|United Kingdom 1
United States|France|Switzerland 1
United States|Germany|Ireland|Spain|United Kingdom 1
United States|Germany|Israel|Netherlands 1
United States|Germany|Italy|Spain|United Kingdom 1
United States|Germany|Poland 1
United States|Germany|Poland|United Kingdom 1
United States|Germany|Puerto Rico 1
United States|Germany|Spain 1
United States|Germany|Sweden|United Kingdom 1
United States|India|Israel 1
United States|Israel|Poland|Spain 1
United States|Italy|Korea, Republic of 1
United States|Italy|Poland 1
United States|Italy|Russian Federation|Spain 1
United States|Italy|Spain 1
United States|Italy|Switzerland|United Kingdom 1
United States|Italy|United Kingdom 1
United States|Kenya|Uganda 1
United States|Korea, Republic of|Spain 1
United States|Korea, Republic of|Spain|United Kingdom 1
United States|Netherlands|Spain|Ukraine|United Kingdom 1
United States|Poland 1
United States|Poland|Spain|Sweden 1
United States|Puerto Rico|Switzerland 1
United States|Russian Federation 1
United States|Saudi Arabia 1
United States|Spain|United Kingdom 1

Sites per Study

Site_count Study_Count
1 1488
2 231
3 165
4 101
5 104
6 80
7 77
8 40
9 40
10 48
11 65
12 34
13 34
14 24
15 30
16 24
17 28
18 19
19 17
20 19
21 24
22 21
23 21
24 13
25 20
26 9
27 11
28 12
29 2
30 13
31 15
32 8
33 5
34 7
35 7
36 6
37 5
38 6
39 7
40 9
41 8
42 7
43 6
44 6
45 6
46 5
47 7
48 5
49 2
50 3
51 2
52 5
53 4
54 3
55 2
56 4
57 4
59 2
60 1
62 5
63 2
65 2
67 3
68 1
69 1
70 2
71 3
72 2
73 2
75 2
76 3
77 2
78 2
79 2
80 1
81 2
82 1
83 1
84 1
85 3
86 1
87 6
90 1
91 4
92 3
94 2
95 2
96 2
97 2
98 2
99 1
101 1
104 2
106 1
107 1
108 2
109 1
110 1
111 2
112 2
113 2
114 4
116 2
117 3
118 1
119 1
121 1
123 2
126 2
128 1
129 1
131 4
134 2
140 1
143 1
144 2
145 1
147 1
150 2
151 1
152 3
153 1
157 1
158 1
159 1
160 2
161 2
162 1
164 1
165 1
167 1
171 1
173 1
175 1
176 2
178 1
180 1
183 1
186 1
190 1
192 1
195 1
199 1
200 1
202 1
203 1
204 1
206 2
211 1
212 1
215 1
216 1
222 1
226 1
227 1
235 1
240 1
241 1
244 1
246 1
250 1
257 1
259 1
261 1
273 1
282 1
319 1
326 1
338 1
393 1
396 1
410 1
418 1
423 2
483 1
510 1
520 1
539 1
551 1
796 1
1329 1

Phase

Phase Study_Count
Phase 2 1345
Phase 1 846
Phase 1/Phase 2 419
Phase 3 277
N/A 158
Phase 4 50
Early Phase 1 33
Phase 2/Phase 3 28

Number of Arms

Number_of_Arms Count_of_Studies
1 1760
2 585
3 148
4 90
5 32
6 25
7 12
8 15
9 6
10 4
11 2
12 2
13 1
14 1
15 2
17 2
37 1
NA 468

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 4.00000 2.0000 1.00000 1.0000 1.00000 9.0000 10.0000 1.0000
1st Qu. 12.00000 23.5000 18.00000 30.0000 30.00000 70.0000 162.0000 50.0000
Median 17.00000 50.0000 33.00000 48.0000 47.00000 118.0000 302.0000 75.0000
Mean 29.78788 124.6688 50.92125 68.8263 72.40781 239.8889 470.3606 145.3061
3rd Qu. 26.00000 102.2500 60.00000 84.0000 80.00000 366.0000 546.0000 168.0000
Max. 312.00000 2200.0000 746.00000 422.0000 6452.00000 1000.0000 9350.0000 650.0000

Trial Group Type

group_type Group_Count
Experimental 3894
NA 468
Active Comparator 407
Other 119
Placebo Comparator 54
No Intervention 40
Sham Comparator 2

Intervention Model

intervention_model Study_Count
Single Group Assignment 2045
Parallel Assignment 697
NA 263
Sequential Assignment 122
Crossover Assignment 19
Factorial Assignment 10

Primary Purpose

primary_purpose Study_Count
Treatment 2946
Supportive Care 88
Prevention 34
Diagnostic 32
Other 22
NA 15
Basic Science 14
Screening 3
Health Services Research 2

Observational Studies

Studies by Country

Country Study_Count
United States 105
NA 30
France 24
Korea, Republic of 21
China 14
Italy 11
Japan 8
United Kingdom 7
Spain 5
Germany 4
Denmark 3
Israel 3
Netherlands 3
Serbia 3
Taiwan 3
Canada 2
Russian Federation 2
Switzerland 2
United States|Australia|Canada|Puerto Rico 2
United States|Canada 2
Argentina|Brazil|Chile|Colombia|Guatemala|Mexico|Panama 1
Austria|Belgium|France|Germany|Greece|Ireland|Italy|Portugal|Spain|Sweden|United Kingdom 1
Austria|Brazil|France|Italy|Portugal|Ukraine 1
Austria|France|Germany|Greece|Italy|Netherlands|Spain 1
Austria|Italy|Netherlands|Spain 1
Belgium 1
Belgium|France|Portugal 1
Brazil 1
Brazil|Italy 1
China|Hong Kong|Taiwan 1
China|Korea, Republic of|Malaysia|Singapore 1
France|Italy 1
Guadeloupe|Martinique 1
India 1
Italy|Spain|Switzerland|United Kingdom 1
Italy|Switzerland 1
Macedonia, The Former Yugoslav Republic of 1
Mexico 1
Sweden 1
Tanzania|Uganda 1
Turkey 1
United States|Argentina|Australia|Brazil|China|Japan|United Kingdom 1
United States|Argentina|Brazil|Chile|China|France|Israel|Italy|Korea, Republic of|Slovakia|Spain|Switzerland|United Kingdom|Uruguay 1
United States|Australia|Canada|Puerto Rico|Switzerland 1
United States|Australia|Canada|Switzerland 1
United States|Canada|Germany 1
United States|Canada|Puerto Rico|Switzerland 1
United States|France|Italy|Spain 1
United States|Germany|Italy|United Kingdom 1
United States|Jamaica|Japan 1
United States|Spain 1

Sites per Study

Site_count Study_Count
1 186
2 16
3 5
4 7
5 3
6 3
7 3
8 2
9 2
10 3
11 1
12 2
13 1
14 3
15 4
16 2
17 3
20 1
21 1
22 1
23 1
24 1
25 1
27 1
28 1
31 2
35 1
39 2
40 1
42 1
43 1
48 2
54 1
55 1
56 1
57 1
66 1
68 1
69 1
75 1
76 1
79 1
82 1
83 1
107 1
111 1
130 1
138 1
144 1
183 2
191 1
203 1

Enrollment Metrics

Measure Observational
Min 5.0000
1st Qu 49.5000
Median 135.5000
Mean 966.6655
3rd Qu 401.2500
Max 99999.0000

Observation Model

observational_model Study_Count
Cohort 156
Case-Only 44
NA 31
Other 25
Case-Control 13
Case Control 12
Family-Based 2
Case-Crossover 1
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 146
Retrospective 99
NA 18
Cross-Sectional 13
Other 9

Registries

Studies by Country

Country Study_Count
China 8
Korea, Republic of 7
France 3
NA 3
United States 3
Belgium|France 1
Brazil 1
Czechia 1
Denmark 1
Italy 1
Malawi 1
Russian Federation 1
Spain 1
Taiwan 1
United States|Italy|Romania|Ukraine 1

Sites per Study

Site_count Study_Count
1 24
2 1
6 1
7 1
8 1
9 1
11 1
14 1
24 1
31 1
36 1

Enrollment Metrics

Measure Registries
Min 40.000
1st Qu 200.000
Median 525.000
Mean 2469.618
3rd Qu 1592.750
Max 20000.000

Registry Model

observational_model Study_Count
Cohort 31
Case-Only 3

Time Perspective

time_perspective Study_Count
Prospective 27
Other 5
Cross-Sectional 2

Follow-up

target_duration Study_Count
5 Years 11
10 Years 5
2 Years 5
1 Year 3
20 Years 2
3 Years 2
1 Day 1
13 Years 1
15 Months 1
24 Months 1
36 Months 1
9 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04435743 Efficacy and Safety of Lenalidomide With or Without Rituximab and Other Drugs in B-cell Non-Hodgkin’s Lymphomas https://ClinicalTrials.gov/show/NCT04435743 Recruiting Ruijin Hospital 2022-12-31
NCT04434833 A Single-cell Transcriptome Study in Patients With Non-Hodgkin’s Lymphoma https://ClinicalTrials.gov/show/NCT04434833 Recruiting Ruijin Hospital 2022-06-30
NCT03211702 Geriatric Assessments in Elderly Diffuse Large B-cell Lymphoma Patients-2 (GERIAD2) https://ClinicalTrials.gov/show/NCT03211702 Active, not recruiting Chonbuk National University Hospital 2018-04-30
NCT03816683 A Disease Registry of Patients With Mantle Cell Lymphoma https://ClinicalTrials.gov/show/NCT03816683 Recruiting AstraZeneca 2024-04-30
NCT03546894 A Study to Determine Progression-free Survival (PFS) and Evaluate Participant Experience for Participants With Metastatic Anaplastic Lymphoma Kinase-positive (ALK+) Non-Small Cell Lung Cancer (NSCLC) Treated With Anaplastic Lymphoma Kinase (ALK) Inhibitors https://ClinicalTrials.gov/show/NCT03546894 Recruiting Takeda 2023-10-31
NCT03375619 Long-term Follow-up Study of Patients Receiving CAR-20/19-T Cells https://ClinicalTrials.gov/show/NCT03375619 Recruiting Medical College of Wisconsin 2020-08-01
NCT03374137 Observational Study to Monitor Safety and Effectiveness of Obinutuzumab in Follicular Lymphoma or Previously Untreated Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT03374137 Recruiting Hoffmann-La Roche 2020-09-30
NCT00899015 Assessing Arsenic Trioxide in Young Patients With Leukemia or Lymphoma Who Were Treated on Clinical Trial NCI-00-C-0070J https://ClinicalTrials.gov/show/NCT00899015 Completed National Institutes of Health Clinical Center (CC) NA
NCT03361358 Pre-Screening Study to Identify MTAP Loss in Advanced Solid Tumors or Lymphoma https://ClinicalTrials.gov/show/NCT03361358 Completed Agios Pharmaceuticals, Inc. 2019-09-30
NCT03361020 Obstructive Sleep Apnea in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation https://ClinicalTrials.gov/show/NCT03361020 Recruiting St. Jude Children’s Research Hospital 2023-02-28
NCT03342586 Using a Novel Functional MRI Technique to Evaluate for Neurotoxicity https://ClinicalTrials.gov/show/NCT03342586 Recruiting Memorial Sloan Kettering Cancer Center 2021-11-07
NCT03327571 B-CD30 + Hodgkin Lymphoma International Multi-center Retrospective Study of Treatment Practices and Outcomes https://ClinicalTrials.gov/show/NCT03327571 Completed Takeda 2019-10-31
NCT03323541 Use of Zarzio® in Post-autologous Stem Cell Transplantation Procedure https://ClinicalTrials.gov/show/NCT03323541 Completed University Hospital, Brest 2016-12-31
NCT03297697 Minimal Residual Disease in Peripheral T-cell Lymphoma https://ClinicalTrials.gov/show/NCT03297697 Active, not recruiting Washington University School of Medicine 2021-07-31
NCT03289182 An Observational Study of MabThera Subcutaneous (SC) Safety in Participants With Non-Hodgkin’s Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL) https://ClinicalTrials.gov/show/NCT03289182 Active, not recruiting Hoffmann-La Roche 2020-10-26
NCT03260101 Non-interventional, Long-term Follow-up of Subjects Who Completed ApoGraft-01 Study https://ClinicalTrials.gov/show/NCT03260101 Recruiting Cellect Biotechnology 2021-12-31
NCT03226704 Leukapheresis for CAR-Therapy Manufacturing https://ClinicalTrials.gov/show/NCT03226704 Recruiting National Institutes of Health Clinical Center (CC) 2023-05-01
NCT03200977 Safety of Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Classical Hodgkin Lymphoma (CHL) Treated With Nivolumab https://ClinicalTrials.gov/show/NCT03200977 Recruiting Bristol-Myers Squibb 2022-12-30
NCT03098589 Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL) https://ClinicalTrials.gov/show/NCT03098589 Recruiting Celgene 2021-10-02
NCT03104478 Real Time Molecular Characterization of Diffuse Large B Cell Lymphoma (DLBCL) https://ClinicalTrials.gov/show/NCT03104478 Recruiting The Lymphoma Academic Research Organisation 2020-12-31
NCT03079544 Social Media-based Active Self-report on Incidence and Outcomes of Adverse Events in NK/TCL Patients https://ClinicalTrials.gov/show/NCT03079544 Recruiting Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 2022-12-30
NCT03053024 Study of Bortezomib (BTZ) Treatment on Mantle Cell Lymphoma (MCL) in Chinese Participants https://ClinicalTrials.gov/show/NCT03053024 Completed Xian-Janssen Pharmaceutical Ltd. 2019-09-30
NCT03054883 Observational Study for Patients With Newly Diagnosed (MCL) Not Eligible for High-dose Therapy https://ClinicalTrials.gov/show/NCT03054883 Completed Czech Lymphoma Study Group 2015-12-31
NCT03040206 Risk Stratification of Nodal PTCL https://ClinicalTrials.gov/show/NCT03040206 Completed Chonbuk National University Hospital 2017-06-30
NCT03042247 Prospective Comparison Between FDG-PET/MR and FDG-PET/CT in Classical Hodgkin Lymphoma and DLBC Non-Hodgkin Lymphoma https://ClinicalTrials.gov/show/NCT03042247 Recruiting Federico II University 2020-06-10
NCT03037177 Mediastinal Grey Zone Lymphoma From the LYSA https://ClinicalTrials.gov/show/NCT03037177 Completed Hospices Civils de Lyon 2016-01-31
NCT03000192 HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life https://ClinicalTrials.gov/show/NCT03000192 Active, not recruiting University Hospital Southampton NHS Foundation Trust 2020-12-31
NCT02992223 Retrospective Analysis on Relapsed/Refractory Aggressive Non Hodgkin Lymphoma Treated With Z-BEAM Plus ASCT https://ClinicalTrials.gov/show/NCT02992223 Completed Azienda Ospedaliera Città della Salute e della Scienza di Torino 2015-07-31
NCT02978898 CD180 Overexpression in Follicular Lymphoma https://ClinicalTrials.gov/show/NCT02978898 Completed Hospices Civils de Lyon 2014-06-30
NCT02951871 Causes of Death in Follicular Lymphoma: a Single Center Retrospective Analysis https://ClinicalTrials.gov/show/NCT02951871 Completed Hospices Civils de Lyon 2016-01-31
NCT02945319 Integrated Molecular and Clinical Profiling to Optimize Outcome Prediction in Splenic Marginal Zone Lymphoma https://ClinicalTrials.gov/show/NCT02945319 Active, not recruiting International Extranodal Lymphoma Study Group (IELSG) 2020-06-30
NCT02904577 Indolent Non Follicular Lymphomas Prognostic Project https://ClinicalTrials.gov/show/NCT02904577 Active, not recruiting Fondazione Italiana Linfomi ONLUS 2024-09-30
NCT02108444 Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients https://ClinicalTrials.gov/show/NCT02108444 Completed Peking University 2013-12-31
NCT02848274 ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome https://ClinicalTrials.gov/show/NCT02848274 Recruiting Stanford University 2022-03-31
NCT02840747 Tissue Repository: CTCL Collection Protocol https://ClinicalTrials.gov/show/NCT02840747 Recruiting Columbia University 2021-01-31
NCT02823327 Clinical Factors and Gene Expression Analysis for Prognosis in Tissue Samples From Patients With AIDS-Related Primary Effusion Lymphoma https://ClinicalTrials.gov/show/NCT02823327 Recruiting AIDS Malignancy Consortium 2020-12-31
NCT02795013 Genetic Study of Families With High Frequency of Hodgkin Lymphoma https://ClinicalTrials.gov/show/NCT02795013 Completed St. Jude Children’s Research Hospital 2018-02-27
NCT02788916 A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas https://ClinicalTrials.gov/show/NCT02788916 Completed Takeda 2016-11-10
NCT02708732 Utility Study in Diffuse Large B-Cell Lymphoma (DLBCL) https://ClinicalTrials.gov/show/NCT02708732 Completed Hoffmann-La Roche 2016-10-31
NCT02655744 Prospective Neurobehavioral Outcomes Follow-up in Primary CNS Lymphoma Patients Treated With Cranial Radiotherapy Combined With or Without MTX-based Chemotherapy According to the Multidisciplinary Treatment Guidelines Implemented at a Single Institute https://ClinicalTrials.gov/show/NCT02655744 Recruiting Chang Gung Memorial Hospital 2022-12-31
NCT02633111 DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas https://ClinicalTrials.gov/show/NCT02633111 Recruiting Memorial Sloan Kettering Cancer Center 2021-10-31
NCT02589548 Brazilian Prospective Hodgkin Lymphoma Registry https://ClinicalTrials.gov/show/NCT02589548 Recruiting Universidade Federal do Rio de Janeiro 2020-12-31
NCT01676805 Tissue Collection for Studies of Lymph Cancer https://ClinicalTrials.gov/show/NCT01676805 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00923442 Biology Studies of Hematologic Cancers https://ClinicalTrials.gov/show/NCT00923442 Enrolling by invitation National Institutes of Health Clinical Center (CC) NA
NCT01351545 A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) https://ClinicalTrials.gov/show/NCT01351545 Recruiting Center for International Blood and Marrow Transplant Research 2021-10-31
NCT02559583 Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin’s Lymphoma (NHL) in Latin America https://ClinicalTrials.gov/show/NCT02559583 Completed Janssen-Cilag Ltd. 2016-06-30
NCT02555267 Geriatric Assessments in Elderly Diffuse Large B-cell Lymphoma https://ClinicalTrials.gov/show/NCT02555267 Active, not recruiting Chonbuk National University Hospital 2017-07-31
NCT02536664 Non-Interventional Study to Examine Rituximab Treatment in Follicular Lymphoma Participants https://ClinicalTrials.gov/show/NCT02536664 Completed Hoffmann-La Roche 2014-06-30
NCT02520895 Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT02520895 Completed Hospices Civils de Lyon 2013-10-31
NCT02520908 Benefit of Allogeneic Haematopoietic Stem Cells in Cutaneous T-cell Lymphomas Epidermotropic With Advanced Stage and Poor Prognosis https://ClinicalTrials.gov/show/NCT02520908 Recruiting Assistance Publique - Hôpitaux de Paris 2021-09-30
NCT02504190 Non-interventional Study on TEAM Conditioning in Patients With Lymphoma (TEAM) https://ClinicalTrials.gov/show/NCT02504190 Completed Association for Training, Education, and Research in Hematology, Immunology, and Transplantation 2019-11-30
NCT03571997 Study of Prognostic Factors in Adult Lymphoblastic Lymphoma https://ClinicalTrials.gov/show/NCT03571997 Recruiting PETHEMA Foundation 2020-09-01
NCT02486952 MabThera (Rituximab) in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma https://ClinicalTrials.gov/show/NCT02486952 Completed Hoffmann-La Roche 2011-01-31
NCT02476734 FDG-PET/CT Imaging as Early Predictor of DP https://ClinicalTrials.gov/show/NCT02476734 Completed University of Pennsylvania 2016-02-29
NCT02472756 A Study of Rituximab in Combination With Chemotherapy in Relapsed/Refractory Follicular Lymphoma https://ClinicalTrials.gov/show/NCT02472756 Completed Hoffmann-La Roche 2014-05-30
NCT02474160 Collection and Storage of Tissue and Blood Samples From Patients With Cancer https://ClinicalTrials.gov/show/NCT02474160 Recruiting National Cancer Institute (NCI) 2021-05-04
NCT02461290 Rituximab Therapy in Follicular Lymphoma in Combination With Chemotherapy - REFLECT 1 https://ClinicalTrials.gov/show/NCT02461290 Completed Hoffmann-La Roche 2013-11-30
NCT02404818 Early Markers of Radiation-Induced Cardiac Injury in Hodgkin Lymphoma Treated With Radiation Therapy https://ClinicalTrials.gov/show/NCT02404818 Active, not recruiting University of Florida 2022-04-30
NCT02386813 International Extranodal NK/T-cell Lymphoma Project https://ClinicalTrials.gov/show/NCT02386813 Completed Samsung Medical Center 2015-06-30
NCT02370446 Testing a Personalize Medication Log for Patients With Lymphoma https://ClinicalTrials.gov/show/NCT02370446 Completed Memorial Sloan Kettering Cancer Center 2017-01-31
NCT02364050 Prospective Data Collection of Elderly Patients With DLBCL Receiving at the Time of Diagnosis VGM https://ClinicalTrials.gov/show/NCT02364050 Active, not recruiting Fondazione Italiana Linfomi ONLUS 2017-12-31
NCT02354846 An Observational Study on Evaluating the Efficacy and Safety of Preemptive Antiviral Therapy With Tenofovir in HBsAg-positive Patients With Diffuse Large B-cell Lymphoma Receiving Rituximab-CHOP Chemotherapy (SPEED Study) https://ClinicalTrials.gov/show/NCT02354846 Recruiting Yonsei University 2021-03-31
NCT02341781 Observational Study of Lenalidomide in Subjects With Mantle Cell Lymphoma Who Failed Ibrutinib Treatment https://ClinicalTrials.gov/show/NCT02341781 Completed Celgene 2016-09-30
NCT02316613 Prospective Observational Study on the Management of Patients With Relapsed or Refractory Follicular Lymphoma (OLYMPE) https://ClinicalTrials.gov/show/NCT02316613 Completed Hoffmann-La Roche 2013-04-30
NCT02300402 Detection and Characterization of Residual Masses in Lymphomas https://ClinicalTrials.gov/show/NCT02300402 Recruiting The Lymphoma Academic Research Organisation 2020-12-31
NCT02240316 An Observational Study of Patients With Malignant Lymphomas Treated With MabThera® SC in Everyday Clinical Practice https://ClinicalTrials.gov/show/NCT02240316 Completed Hoffmann-La Roche 2019-07-22
NCT02199288 Effectiveness, Safety & Nurse Management Study of MabThera SC in Patients With Non-Hodgkin’s Lymphoma: Real-Life Setting https://ClinicalTrials.gov/show/NCT02199288 Completed Hoffmann-La Roche 2016-07-31
NCT02139592 Brentuximab Vedotin (Recombinant) for IV Infusion - Special Drug Use Surveillance (All-case Surveillance) “Relapsed or Refractory CD30+ Hodgkin’s Lymphoma or Anaplastic Large Cell Lymphoma” https://ClinicalTrials.gov/show/NCT02139592 Completed Takeda 2017-06-30
NCT02106611 Tissue and Functional Assessment of Myocardial Injury in Hodgkin Lymphoma (HL) Survivors https://ClinicalTrials.gov/show/NCT02106611 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-04-30
NCT02072967 Ribomustin in the Second Line Therapy of Relapsed or Refractory Indolent B-cell Non-Hodgkin’s Lymphoma https://ClinicalTrials.gov/show/NCT02072967 Completed Astellas Pharma Inc 2015-10-31
NCT02069639 TARC After alloSCT in Hodgkin’s Lymphoma https://ClinicalTrials.gov/show/NCT02069639 Completed Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 2014-01-31
NCT02060435 Epstein-Barr Virus Status in Diffuse Large B Cell Lymphoma https://ClinicalTrials.gov/show/NCT02060435 Completed Samsung Medical Center 2013-12-31
NCT01311232 Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab https://ClinicalTrials.gov/show/NCT01311232 Completed Samsung Medical Center 2012-12-01
NCT01287923 Assessment of Blood Biomarkers by DNA Microarrays in Patients With Aggressive Lymphoma BMS_LyTrans https://ClinicalTrials.gov/show/NCT01287923 Completed Rennes University Hospital 2017-06-08
NCT03190928 Clonal Evolution in Follicular Lymphoma https://ClinicalTrials.gov/show/NCT03190928 Recruiting National Institutes of Health Clinical Center (CC) 2022-07-01
NCT03356678 Pralatrexate for Relapsed or Refractory Peripheral T-cell Lymphoma https://ClinicalTrials.gov/show/NCT03356678 Completed Samsung Medical Center 2017-06-30
NCT01941680 High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant https://ClinicalTrials.gov/show/NCT01941680 Active, not recruiting University Hospital Center of Martinique 2018-02-28
NCT01820117 Brain Integrity in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation https://ClinicalTrials.gov/show/NCT01820117 Completed St. Jude Children’s Research Hospital 2018-02-20
NCT01809600 Retrospective Analysis of Rituximab-containing Immunochemotherapy for Burkitt’s or Burkitt-like Lymphoma in Adults https://ClinicalTrials.gov/show/NCT01809600 Completed Gachon University Gil Medical Center 2014-03-31
NCT01793233 Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas https://ClinicalTrials.gov/show/NCT01793233 Active, not recruiting Children’s Oncology Group 2020-12-31
NCT01790152 Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment https://ClinicalTrials.gov/show/NCT01790152 Recruiting Children’s Oncology Group 2022-03-30
NCT01788839 Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma https://ClinicalTrials.gov/show/NCT01788839 Recruiting Memorial Sloan Kettering Cancer Center 2021-02-28
NCT01789060 p-AKT Expression on Clinical Outcomes in Malignant Lymphoma https://ClinicalTrials.gov/show/NCT01789060 Completed Samsung Medical Center 2013-02-28
NCT01731379 Optical Detection of Peripheral Nerve Bundles During Surgery https://ClinicalTrials.gov/show/NCT01731379 Completed Philips Healthcare 2014-01-31
NCT04150328 Lenalidomide Monotherapy in R/R DLBCL https://ClinicalTrials.gov/show/NCT04150328 Recruiting MorphoSys AG 2019-08-29
NCT01684865 An Observational Study of First-Line Maintenance Rituximab (MabThera/Rituxan) in Participants With Follicular Non-Hodgkin’s Lymphoma https://ClinicalTrials.gov/show/NCT01684865 Completed Hoffmann-La Roche 2017-11-27
NCT01664936 Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph Nodes https://ClinicalTrials.gov/show/NCT01664936 Completed Memorial Sloan Kettering Cancer Center 2018-04-03
NCT01660776 BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology https://ClinicalTrials.gov/show/NCT01660776 Completed Rennes University Hospital 2017-10-02
NCT01660568 Gemcitabine in NK/T Cell Lymphoma https://ClinicalTrials.gov/show/NCT01660568 Completed Samsung Medical Center 2013-01-31
NCT01639716 Lymphoma and T Helper 2 Cytokines Relationship With Prognostic Markers https://ClinicalTrials.gov/show/NCT01639716 Completed Guler, Nil, M.D. 2012-05-31
NCT01623856 Studying Genes Associated With Non-Hodgkin Lymphoma in Young Patients https://ClinicalTrials.gov/show/NCT01623856 Completed Children’s Oncology Group 2012-06-30
NCT01626547 Biosimilar Retacritâ„¢ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology https://ClinicalTrials.gov/show/NCT01626547 Completed Hospira, now a wholly owned subsidiary of Pfizer 2012-12-31
NCT01606605 Treatment Resistance Related With Gene Expression Profile of Diffuse Large B-cell Lymphoma https://ClinicalTrials.gov/show/NCT01606605 Completed Samsung Medical Center 2012-12-31
NCT01584141 Study of Lymphoma in Asia https://ClinicalTrials.gov/show/NCT01584141 Completed National Institutes of Health Clinical Center (CC) NA
NCT01567722 Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies https://ClinicalTrials.gov/show/NCT01567722 Recruiting AIDS Malignancy Consortium 2020-06-30
NCT01565447 Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Gait Parameters Study https://ClinicalTrials.gov/show/NCT01565447 Active, not recruiting Oregon Health and Science University 2020-12-31
NCT01563861 S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma https://ClinicalTrials.gov/show/NCT01563861 Completed Southwest Oncology Group 2008-06-01
NCT01517581 Brown Fat Activity and White Fat Accumulation https://ClinicalTrials.gov/show/NCT01517581 Completed Children’s Hospital Los Angeles 2011-09-30
NCT01505712 Biomarkers in Tissue Samples From Patients With Hodgkin Lymphoma Enrolled on ECOG-2496 Clinical Trial https://ClinicalTrials.gov/show/NCT01505712 Completed Eastern Cooperative Oncology Group 2012-11-19
NCT01490801 Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma https://ClinicalTrials.gov/show/NCT01490801 Completed Children’s Oncology Group 2016-05-31
NCT01479387 Zevalin Post-marketing Surveillance for Adequateness of Image Interpretation Criteria in Japan https://ClinicalTrials.gov/show/NCT01479387 Completed Bayer NA
NCT01478269 Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen https://ClinicalTrials.gov/show/NCT01478269 Completed Fondazione Italiana Linfomi ONLUS 2011-05-31
NCT01478191 Prognosis of Patients With Relapsed/Refractory Hodgkin Lymphoma Treated With IGEV Induction Therapy Before HDCT With AHSCT https://ClinicalTrials.gov/show/NCT01478191 Completed Fondazione Italiana Linfomi ONLUS NA
NCT01469754 Longitudinal Survey Analysis in Lymphoma Survivors https://ClinicalTrials.gov/show/NCT01469754 Completed Weill Medical College of Cornell University 2013-07-31
NCT01460914 Outcomes of Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With Extracorporeal Photopheresis Treatment https://ClinicalTrials.gov/show/NCT01460914 Active, not recruiting Dartmouth-Hitchcock Medical Center 2050-09-30
NCT01459224 MELT - MRI Evaluation of Lymphoma Treatment https://ClinicalTrials.gov/show/NCT01459224 Completed University College, London 2014-09-30
NCT01406782 DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402 https://ClinicalTrials.gov/show/NCT01406782 Completed Eastern Cooperative Oncology Group 2012-01-13
NCT01402687 SNP-Based Prediction of Oral Mucositis Risk in Patients Receiving Hematopoietic Stem Cell Transplants (HSCT) https://ClinicalTrials.gov/show/NCT01402687 Completed Dana-Farber Cancer Institute 2013-02-28
NCT01390597 Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms https://ClinicalTrials.gov/show/NCT01390597 Completed Eastern Cooperative Oncology Group 2011-08-28
NCT01386697 DIBH Proton Planning https://ClinicalTrials.gov/show/NCT01386697 Completed Abramson Cancer Center of the University of Pennsylvania 2013-06-30
NCT01381705 Biomarkers in Predicting Response to Rituximab Treatment in Samples From Patients With Indolent Follicular Lymphoma https://ClinicalTrials.gov/show/NCT01381705 Completed Eastern Cooperative Oncology Group 2012-07-06
NCT01367457 INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus https://ClinicalTrials.gov/show/NCT01367457 Completed Pfizer 2015-04-30
NCT01366170 Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma https://ClinicalTrials.gov/show/NCT01366170 Completed Children’s Oncology Group 2016-05-31
NCT01366157 Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma https://ClinicalTrials.gov/show/NCT01366157 Completed Children’s Oncology Group 2016-05-31
NCT01341119 Retrospective Analysis of Skin/Soft Tissue Primary NK/T Cell Lymphoma https://ClinicalTrials.gov/show/NCT01341119 Completed Samsung Medical Center NA
NCT01340443 An Observational Study of MabThera/Rituxan (Rituximab) Plus Chemotherapy As First-Line Treatment in Patients With Diffuse Large B-Cell Lymphoma or Follicular Lymphoma https://ClinicalTrials.gov/show/NCT01340443 Completed Hoffmann-La Roche 2016-07-15
NCT01319591 Comparison of Creatinine Clearance Calculation for Estimation of GFR in Patients Receiving HD Methotrexate https://ClinicalTrials.gov/show/NCT01319591 Completed Dana-Farber Cancer Institute 2014-08-31
NCT04419441 Immune Checkpoint Inhibitors and Radiotherapy in Relapsed/Refractory Hodgkin Lymphoma https://ClinicalTrials.gov/show/NCT04419441 Recruiting Ospedale Maggiore Di Trieste 2020-06-30
NCT04423549 Predictive Value of a mRNA Signature and Liquid Biopsy in Diffuse Large B Cell Lymphoma https://ClinicalTrials.gov/show/NCT04423549 Recruiting Sun Yat-sen University 2021-06-30
NCT04423536 Predictive Value of a SNP Signature and Liquid Biopsy in Natural Killer T-cell Lymphoma https://ClinicalTrials.gov/show/NCT04423536 Recruiting Sun Yat-sen University 2021-06-30
NCT04396119 Developing Lung Cancer Screening in Hodgkin Lymphoma Survivors: a Qualitative Study https://ClinicalTrials.gov/show/NCT04396119 Recruiting The Christie NHS Foundation Trust 2020-08-31
NCT04354402 Follow-up Study of SyB L-0501 in Combination With Rituximab to Treat DLBCL https://ClinicalTrials.gov/show/NCT04354402 Enrolling by invitation SymBio Pharmaceuticals 2020-12-31
NCT04319237 Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes https://ClinicalTrials.gov/show/NCT04319237 Recruiting H. Lee Moffitt Cancer Center and Research Institute 2022-06-30
NCT04317313 Prediction of Outcome Using Pretreatment 18F-FDG PET/CT Radiomic Features in Diffuse Large B-cell Lymphoma https://ClinicalTrials.gov/show/NCT04317313 Completed Second Affiliated Hospital, School of Medicine, Zhejiang University 2018-09-30
NCT04300998 Study of CAR-T Therapy in Older Patients https://ClinicalTrials.gov/show/NCT04300998 Recruiting Memorial Sloan Kettering Cancer Center 2021-03-04
NCT04298619 Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission https://ClinicalTrials.gov/show/NCT04298619 Completed Federico II University 2016-04-30
NCT04263935 Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma https://ClinicalTrials.gov/show/NCT04263935 Recruiting Henan Cancer Hospital 2023-02-28
NCT04107285 Looking at Brain Changes in People With Lymphoma Receiving CAR-T Therapy https://ClinicalTrials.gov/show/NCT04107285 Recruiting Memorial Sloan Kettering Cancer Center 2021-09-30
NCT04109872 Lenalidomide Observational Study in Patients With Mantle Lymphoma in Relapse/Refraction. Spanish Programme RRMCL Results. https://ClinicalTrials.gov/show/NCT04109872 Recruiting Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 2020-06-15
NCT04088422 Cell Free DNA in Mature B-cell Lymphoma https://ClinicalTrials.gov/show/NCT04088422 Recruiting Ruijin Hospital 2024-04-30
NCT04061850 Ibrutinib for Relapsed or Refractory Mantle Cell Lymphoma https://ClinicalTrials.gov/show/NCT04061850 Recruiting Samsung Medical Center 2020-06-30
NCT04055558 Lymphoproliferative Disorders During the Treatment of Childhood Acute Lymphoblastic Leukemia/Lymphoma https://ClinicalTrials.gov/show/NCT04055558 Recruiting Rabin Medical Center 2019-12-18
NCT04053439 Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications https://ClinicalTrials.gov/show/NCT04053439 Recruiting Sunnybrook Health Sciences Centre 2023-09-30
NCT04048395 Clinical Outcomes of Early-progressed Follicular Lymphoma in Korea https://ClinicalTrials.gov/show/NCT04048395 Recruiting Samsung Medical Center 2020-04-30
NCT02682667 Biospecimen Procurement for Experimental Transplantation and Immunology Branch Immunotherapy Protocols https://ClinicalTrials.gov/show/NCT02682667 Recruiting National Institutes of Health Clinical Center (CC) 2025-12-01
NCT04037189 Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia https://ClinicalTrials.gov/show/NCT04037189 Recruiting Rabin Medical Center 2021-07-28
NCT04034056 Untreated FolliculaR Lymphoma Treated With OBinituzumAb in a Non-interventional Study (URBAN) https://ClinicalTrials.gov/show/NCT04034056 Recruiting Hoffmann-La Roche 2024-12-30
NCT04028804 FLT PET: A Pilot Study in Lymphoma Patients https://ClinicalTrials.gov/show/NCT04028804 Completed The Hospital for Sick Children 2014-12-31
NCT03977623 Genomic Evaluation in Patients With Diffuse Large B Cell Lymphoma After First Relapse/Progression https://ClinicalTrials.gov/show/NCT03977623 Recruiting Samsung Medical Center 2022-02-28
NCT03973164 The Value of Pelvic Magnetic Resonance Imaging in Detecting Bone Marrow Infiltration of Lymphoma https://ClinicalTrials.gov/show/NCT03973164 Completed Guangxi Medical University 2019-05-22
NCT03969693 Lymphoma Patients Undergoing Mediastinal Radiotherapy in the Era of Modern Chemoradiation https://ClinicalTrials.gov/show/NCT03969693 Recruiting Chang Gung Memorial Hospital 2020-08-31
NCT03942263 A Study to Describe Treatment Patterns and Disease Control in Participants With cHL and sALCL in Routine Clinical Practice in the Russian Federation https://ClinicalTrials.gov/show/NCT03942263 Recruiting Takeda 2023-05-10
NCT03932279 Characterization of the Microbiome in Cutaneous T Cell Lymphoma https://ClinicalTrials.gov/show/NCT03932279 Recruiting Northwestern University 2020-12-31
NCT03860376 Ex Vivo Drug Sensitivity Testing and Mutation Profiling https://ClinicalTrials.gov/show/NCT03860376 Recruiting Florida International University 2022-12-15
NCT03859544 Molecular Prognosis of Lymphomas of the Central Nervous System (ALYCE-molecular) https://ClinicalTrials.gov/show/NCT03859544 Recruiting Hospices Civils de Lyon 2020-01-01
NCT03742921 ISTODAX® for Intravenous Infusion Drug Use Results Survey- Relapsed or Refractory Peripheral T-Cell Lymphoma https://ClinicalTrials.gov/show/NCT03742921 Recruiting Celgene 2023-04-17
NCT03729609 Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion “Untreated CD30-Positive Hodgkin’s Lymphoma” https://ClinicalTrials.gov/show/NCT03729609 Recruiting Takeda 2022-05-31
NCT03681938 Indication to Transplant Patients With High Risk B Cells Lymphoma in Metabolic Complete Remission? https://ClinicalTrials.gov/show/NCT03681938 Active, not recruiting Institut Paoli-Calmettes 2019-07-28
NCT03672084 Allo-HSCT as First-line Consolidation in High-risk PTCL https://ClinicalTrials.gov/show/NCT03672084 Recruiting Peking University People’s Hospital 2021-08-31
NCT03672682 SMOLY : Phenotype and Functions of Monocyte Subtypes in High Grade B Lymphoma: Towards New Biomarkers? https://ClinicalTrials.gov/show/NCT03672682 Completed Rennes University Hospital 2019-09-01
NCT03664336 Refractory Diffuse Large B-cell Lymphoma https://ClinicalTrials.gov/show/NCT03664336 Completed Hospices Civils de Lyon 2017-07-31
NCT03664323 Anti-PD-1 and Chemotherapy for R/R Hodgkin Lymphoma https://ClinicalTrials.gov/show/NCT03664323 Completed Hospices Civils de Lyon 2018-01-31
NCT03663894 Clinical Characteristics and Outcomes of Relapsed Follicular Lymphoma After Autologous Stem Cell Transplantation at Rituximab Era https://ClinicalTrials.gov/show/NCT03663894 Completed Hospices Civils de Lyon 2017-12-15
NCT03647124 Non-Interventional Study in Patients With Relapsed or Refractory Mantle Cell Lymphoma (R/R MCL) to Investigate the Association of Lenalidomide With Tumor Flare Reaction and High Tumor Burden https://ClinicalTrials.gov/show/NCT03647124 Recruiting Celgene 2026-12-31
NCT03603847 Prospective Study of the Prognostic Value of New Markers in Adults With ALK-positive Large Anaplastic Lymphoma https://ClinicalTrials.gov/show/NCT03603847 Recruiting The Lymphoma Academic Research Organisation 2023-07-31
NCT03597685 Pesticide Associated Lymphomas: Expression of Treatment Resistance Genes https://ClinicalTrials.gov/show/NCT03597685 Completed University Hospital, Montpellier 2018-12-31
NCT03568929 Safety Profile of Idelalisib in Patients With Refractory Follicular Lymphoma https://ClinicalTrials.gov/show/NCT03568929 Recruiting Gilead Sciences 2020-10-31
NCT03546101 Early Detection of Epstein-Barr Virus Related Disease. https://ClinicalTrials.gov/show/NCT03546101 Active, not recruiting University of Aarhus 2022-03-01
NCT03535948 Elderly Hodgkin Lymphoma Patients Treated With Chemoradiotherapy https://ClinicalTrials.gov/show/NCT03535948 Active, not recruiting Central Hospital, Nancy, France 2019-11-30
NCT03525665 Study on the Role of FDG-PET in Patients With FL at Time of Relapse/Progression https://ClinicalTrials.gov/show/NCT03525665 Completed Fondazione Italiana Linfomi ONLUS 2019-12-30
NCT03480087 Subclinical Cardio-toxicities Evaluation With Strain Rate Echocardiography After Chemotherapy and/or Mediastinal Radiotherapy in Patient With Lymphoma https://ClinicalTrials.gov/show/NCT03480087 Recruiting Azienda Ospedaliera Città della Salute e della Scienza di Torino 2020-07-31
NCT03476655 Clinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated With Ibrutinib: A Medical Chart Review From India https://ClinicalTrials.gov/show/NCT03476655 Completed Johnson & Johnson Private Limited 2019-05-14
NCT03469921 Unicentric Retrospective Analysis of a Cohort of 602 Young Adult and Adolescent Patients (AJA), Aged 15 to 30 Years, With Haematological Malignancies, and Managed Between 2000 and 2016 https://ClinicalTrials.gov/show/NCT03469921 Completed Institut Paoli-Calmettes 2016-12-31
NCT03436602 Personalized Risk Stratification Model of Follicular Lymphoma Patients https://ClinicalTrials.gov/show/NCT03436602 Recruiting Oncology Institute of Southern Switzerland 2021-03-31
NCT03413644 Evaluation of ClearLLab Leukemia and Lymphoma Panels https://ClinicalTrials.gov/show/NCT03413644 Completed Beckman Coulter, Inc. 2018-04-27
NCT01264822 Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori https://ClinicalTrials.gov/show/NCT01264822 Completed Eisai Inc. 2016-02-29
NCT01266668 The Impact of Rituximab in Patients With Primary Breast Diffuse Large B Cell Lymphoma (DLBCL) https://ClinicalTrials.gov/show/NCT01266668 Completed Chonbuk National University Hospital 2011-05-31
NCT01248000 The Use of FDG-PET in Patient With Hodgkin Lymphoma: a Population Based Study From Northern Italy https://ClinicalTrials.gov/show/NCT01248000 Completed Gruppo Italiano Studio Linfomi NA
NCT01230008 Radiotherapy in Primary Mediastinal Lymphoma https://ClinicalTrials.gov/show/NCT01230008 Completed Instituto Mexicano del Seguro Social 2007-06-30
NCT01228461 Risk of Fatigue in Adolescent and Young Adult Hodgkin Lymphoma Patients https://ClinicalTrials.gov/show/NCT01228461 Completed Vanderbilt University Medical Center 2012-01-31
NCT01199562 Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT01199562 Completed City of Hope Medical Center 2013-12-31
NCT01196520 Epidemiology of Burkitt Lymphoma in East Africa Children or Minors (EMBLEM) https://ClinicalTrials.gov/show/NCT01196520 Completed National Institutes of Health Clinical Center (CC) 2015-12-31
NCT01185886 Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01185886 Active, not recruiting European Organisation for Research and Treatment of Cancer - EORTC 2021-06-30
NCT01164696 A Prospective Observational Study to Evaluate the Quality of Life and the Costs in a Real Life Setting in Patients Who Are Treated With 90Y-Zevalin https://ClinicalTrials.gov/show/NCT01164696 Completed Bayer 2009-05-31
NCT01150643 Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab https://ClinicalTrials.gov/show/NCT01150643 Completed Eastern Cooperative Oncology Group 2011-01-06
NCT01142674 T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma https://ClinicalTrials.gov/show/NCT01142674 Completed Associazione Angela Serra per la ricerca sul cancro 2016-07-31
NCT01137825 Registry of Older Patients With Cancer https://ClinicalTrials.gov/show/NCT01137825 Active, not recruiting UNC Lineberger Comprehensive Cancer Center 2030-06-30
NCT01137643 Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT01137643 Active, not recruiting UNC Lineberger Comprehensive Cancer Center 2040-07-31
NCT01131221 S8947-9800-9911-0016A Vitamin D Insufficiency in Determining Prognosis in Patients With Newly Diagnosed Follicular Lymphoma https://ClinicalTrials.gov/show/NCT01131221 Completed Southwest Oncology Group 2011-09-30
NCT01131208 Biomarkers in Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab https://ClinicalTrials.gov/show/NCT01131208 Completed Eastern Cooperative Oncology Group 2010-08-21
NCT01117142 A Study of the Kinetics of Lymphoid Cells in Patients With Monoclonal B-cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma (MCL) and Healthy Volunteers https://ClinicalTrials.gov/show/NCT01117142 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT01111201 International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients https://ClinicalTrials.gov/show/NCT01111201 Completed Memorial Sloan Kettering Cancer Center 2012-03-31
NCT01110733 Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry https://ClinicalTrials.gov/show/NCT01110733 Completed Acrotech Biopharma LLC 2019-12-31
NCT01057459 DNA Analysis in Predicting Response to Antibody Therapy in Patients With Follicular Lymphoma Treated on Clinical Trials CALGB-50402 or CALGB-50701 https://ClinicalTrials.gov/show/NCT01057459 Completed Alliance for Clinical Trials in Oncology 2014-06-23
NCT01043302 Multicenter Cross Sectional Study of Primary Intestine Lymphoma https://ClinicalTrials.gov/show/NCT01043302 Completed Samsung Medical Center 2010-03-31
NCT01000753 Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma https://ClinicalTrials.gov/show/NCT01000753 Active, not recruiting Children’s Oncology Group 2007-06-01
NCT01000558 SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma https://ClinicalTrials.gov/show/NCT01000558 Completed Southwest Oncology Group 2011-07-31
NCT00993694 Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone https://ClinicalTrials.gov/show/NCT00993694 Completed Vanderbilt University Medical Center 2009-12-31
NCT00985699 S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma https://ClinicalTrials.gov/show/NCT00985699 Completed Southwest Oncology Group 2014-06-30
NCT00981097 Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma https://ClinicalTrials.gov/show/NCT00981097 Completed AIDS Malignancy Consortium 2013-06-30
NCT00964821 Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00964821 Completed City of Hope Medical Center 2013-05-31
NCT00956475 Quality of Life in Younger Leukemia and Lymphoma Survivors https://ClinicalTrials.gov/show/NCT00956475 Completed Case Comprehensive Cancer Center 2010-09-30
NCT00949741 Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin’s Lymphoma Patients https://ClinicalTrials.gov/show/NCT00949741 Completed Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie 2011-10-31
NCT00944567 A Clinico-Pathologic Study of Primary Mediastinal B-Cell Lymphoma https://ClinicalTrials.gov/show/NCT00944567 Completed International Extranodal Lymphoma Study Group (IELSG) 2011-05-31
NCT00933127 S8809-S9800-S9911-S9704-A Study of Blood and Tissue Samples From Patients With Follicular Lymphoma Treated With Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone https://ClinicalTrials.gov/show/NCT00933127 Completed Southwest Oncology Group 2012-06-30
NCT00928096 Breathing Adapted Radiotherapy for Mediastinal Lymphoma https://ClinicalTrials.gov/show/NCT00928096 Completed Rigshospitalet, Denmark 2013-05-31
NCT00920738 Metabolic Syndrome in Childhood Cancer Survivors https://ClinicalTrials.gov/show/NCT00920738 Completed University of Minnesota 2010-07-31
NCT00915096 Positron Emission Tomography (PET)-Scan in the Evaluation of High Tumor Burden Follicular Lymphoma https://ClinicalTrials.gov/show/NCT00915096 Completed Lymphoma Study Association 2011-05-10
NCT00923507 Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL) https://ClinicalTrials.gov/show/NCT00923507 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00903890 Cardiac Effects in Long-Term Survivors of Hodgkin’s and Non-Hodgkin’s Lymphoma https://ClinicalTrials.gov/show/NCT00903890 Active, not recruiting University of Rochester 2018-11-30
NCT00903812 IMPACT Non Hodgkins Lymphoma (NHL) Study https://ClinicalTrials.gov/show/NCT00903812 Completed Amgen 2008-12-31
NCT00902434 Non-Hodgkin Lymphoma in Elderly Patients Above the Age of 80 in the Rituximab Era https://ClinicalTrials.gov/show/NCT00902434 Completed Oncology Specialists, S.C. 2011-02-28
NCT00900250 Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma https://ClinicalTrials.gov/show/NCT00900250 Completed Children’s Oncology Group 2019-03-31
NCT00900484 SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin’s Lymphoma https://ClinicalTrials.gov/show/NCT00900484 Completed Southwest Oncology Group 2011-07-31
NCT00898963 Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496 https://ClinicalTrials.gov/show/NCT00898963 Completed Eastern Cooperative Oncology Group 2011-12-21
NCT00898872 SWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial https://ClinicalTrials.gov/show/NCT00898872 Completed Southwest Oncology Group 2011-07-31
NCT00898755 Collecting and Storing Tissue From Young Patients With Cancer https://ClinicalTrials.gov/show/NCT00898755 Completed Children’s Oncology Group 2008-07-17
NCT00898157 Study of Biomarkers Using Tissue Samples From Older Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab on Clinical Trial ECOG-E4494 https://ClinicalTrials.gov/show/NCT00898157 Completed Eastern Cooperative Oncology Group 2008-09-24
NCT00897923 Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin’s Lymphoma https://ClinicalTrials.gov/show/NCT00897923 Completed Mayo Clinic 2012-02-10
NCT00897325 Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma https://ClinicalTrials.gov/show/NCT00897325 Completed Children’s Oncology Group 2019-12-31
NCT00896922 S8809-S9800-S9911TM- Biological Markers in Patients With Follicular Lymphoma Treated on Clinical Trial SWOG-8809, SWOG-9800, or SWOG-9911 https://ClinicalTrials.gov/show/NCT00896922 Completed Southwest Oncology Group 2009-10-31
NCT00896662 Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202 https://ClinicalTrials.gov/show/NCT00896662 Completed Vanderbilt-Ingram Cancer Center 2007-10-31
NCT00889278 Higher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT00889278 Completed Dartmouth-Hitchcock Medical Center 2012-03-01
NCT03930043 A Metagenome-wide Association Study of Gut Microbiota in Gastrointestinal Non-Hodgkin’s Lymphoma Patients https://ClinicalTrials.gov/show/NCT03930043 Recruiting Ruijin Hospital 2020-09-30
NCT04183569 Identification Predictive Markers of Immunochemotherapy Response to the Primary Cutaneous Diffuse Large B Cell Lymphoma https://ClinicalTrials.gov/show/NCT04183569 Active, not recruiting University Hospital, Bordeaux 2020-05-01
NCT03797170 Design of New Personalized Therapeutic Approaches for Diffuse Large B-cell Lymphoma https://ClinicalTrials.gov/show/NCT03797170 Recruiting University of Bologna 2020-07-20
NCT01369784 Prognostic Value of Clinical and Biological Factors in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma https://ClinicalTrials.gov/show/NCT01369784 Completed Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 2011-03-31
NCT00822432 Coproporphyrine Isomers and Methotrexate Elimination https://ClinicalTrials.gov/show/NCT00822432 Completed Assistance Publique - Hôpitaux de Paris 2011-08-31
NCT03690895 Long-term Outcome of AIDS-related Primary Central Nervous System Lymphoma Treated With High Dose Methotrexate and Combined Antiretroviral Therapy https://ClinicalTrials.gov/show/NCT03690895 Completed Fondation Ophtalmologique Adolphe de Rothschild 2016-10-01
NCT01483664 Communication Skills Intervention to Promote Transition Into Survivorship https://ClinicalTrials.gov/show/NCT01483664 Active, not recruiting Memorial Sloan Kettering Cancer Center 2020-11-30
NCT01382082 Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy https://ClinicalTrials.gov/show/NCT01382082 Active, not recruiting University of Rochester 2024-06-14
NCT01563874 Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins https://ClinicalTrials.gov/show/NCT01563874 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001686 Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases https://ClinicalTrials.gov/show/NCT00001686 Active, not recruiting National Institutes of Health Clinical Center (CC) NA
NCT04213209 Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion “Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma” https://ClinicalTrials.gov/show/NCT04213209 Recruiting Takeda 2022-12-31
NCT04006561 Prospective Neurobehavioral Functions in Newly-diagnosed Patients With Primary CNS Lymphoma Treated With Hyperfractionated Conformal Whole-brain Radiation Therapy Plus Simultaneous Integrated Boost https://ClinicalTrials.gov/show/NCT04006561 Recruiting Chang Gung Memorial Hospital 2022-02-28
NCT04005703 Whole-body MRI in Pediatric Hodgkin’s Lymphoma https://ClinicalTrials.gov/show/NCT04005703 Active, not recruiting UMC Utrecht 2016-12-31
NCT03425591 A Study of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT03425591 Recruiting Janssen-Cilag Ltd. 2022-05-22
NCT03065790 Early FDG PET/CT Imaging as a Measure of Response in Patients With Non-Hodgkin Lymphoma on Lenalidomide https://ClinicalTrials.gov/show/NCT03065790 Active, not recruiting Abramson Cancer Center of the University of Pennsylvania 2021-02-06
NCT03288415 SMZL Molecular Prognostic Index https://ClinicalTrials.gov/show/NCT03288415 Active, not recruiting Oncology Institute of Southern Switzerland 2020-06-30
NCT03050268 Familial Investigations of Childhood Cancer Predisposition https://ClinicalTrials.gov/show/NCT03050268 Recruiting St. Jude Children’s Research Hospital 2037-03-31
NCT03062072 Emergence of Chemotherapy Related Hyperglycemia in nOn-diabetic Patients https://ClinicalTrials.gov/show/NCT03062072 Recruiting National Cancer Center, Korea 2017-12-31
NCT01087333 Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment https://ClinicalTrials.gov/show/NCT01087333 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT04320992 A Multicenter Prospective Study of “High Risk” Molecular Typing in Patients With Adult T Lymphoblastic Lymphoma https://ClinicalTrials.gov/show/NCT04320992 Recruiting Sun Yat-sen University 2023-03-31
NCT00744120 Lymphoma Follow-up https://ClinicalTrials.gov/show/NCT00744120 Completed National Institutes of Health Clinical Center (CC) 2013-09-30
NCT00741325 Long-Term Follow-up Study for Non-Hodgkin’s Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3101 Study (NCT00103610). https://ClinicalTrials.gov/show/NCT00741325 Completed Sanofi 2011-11-30
NCT00731536 Observational Study on the Occurrence of Hepatosplenic T-cell Lymphoma in Patients of Netherlands https://ClinicalTrials.gov/show/NCT00731536 Completed Centocor Ortho Biotech Services, L.L.C. 2010-04-30
NCT00713882 Health and Psychosocial Outcomes in Long-Term Lymphoma Survivors https://ClinicalTrials.gov/show/NCT00713882 Completed Weill Medical College of Cornell University 2008-11-30
NCT00712556 PET Study in Patients With Non-Hodgkin Lymphoma https://ClinicalTrials.gov/show/NCT00712556 Completed Vanderbilt-Ingram Cancer Center 2009-03-31
NCT00700258 Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR] https://ClinicalTrials.gov/show/NCT00700258 Recruiting Pfizer 2023-12-01
NCT00695422 Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials https://ClinicalTrials.gov/show/NCT00695422 Completed AIDS Malignancy Consortium 2017-04-19
NCT00685997 Whole-body Magnetic Resonance Imaging (MRI) for Staging Malignant Lymphomas https://ClinicalTrials.gov/show/NCT00685997 Completed UMC Utrecht 2012-01-31
NCT00582270 Prospective Study of Possible Infectious Disease - Associated Antigen Drive in Previously Untreated Indolent Lymphoma https://ClinicalTrials.gov/show/NCT00582270 Completed Memorial Sloan Kettering Cancer Center 2014-08-31
NCT00581737 Cognitive Functioning and Quality of Life in CNS Lymphoma https://ClinicalTrials.gov/show/NCT00581737 Completed Memorial Sloan Kettering Cancer Center 2009-08-31
NCT00577538 Prevalence of Lymphoma in IBD https://ClinicalTrials.gov/show/NCT00577538 Completed Indiana University 2008-10-31
NCT00510315 Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00510315 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-01-31
NCT00487513 Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical Trials https://ClinicalTrials.gov/show/NCT00487513 Completed Dana-Farber Cancer Institute 2017-01-31
NCT00461084 Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma https://ClinicalTrials.gov/show/NCT00461084 Completed Memorial Sloan Kettering Cancer Center 2014-09-30
NCT00440817 An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn’s Disease. https://ClinicalTrials.gov/show/NCT00440817 Completed Centocor Ortho Biotech Services, L.L.C. 2006-08-31
NCT00430053 Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma https://ClinicalTrials.gov/show/NCT00430053 Completed National Institutes of Health Clinical Center (CC) NA
NCT00416312 Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin’s Lymphoma https://ClinicalTrials.gov/show/NCT00416312 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2009-10-31
NCT00398177 Clinical and Pathologic Studies in Non-Hodgkin’s Lymphoma and Hodgkin’s Disease https://ClinicalTrials.gov/show/NCT00398177 Recruiting Stanford University 2099-01-31
NCT00339963 Genome Expression in Lymphoma, Leukemia and Multiple Myeloma https://ClinicalTrials.gov/show/NCT00339963 Completed National Institutes of Health Clinical Center (CC) NA
NCT00341952 Interdisciplinary Case-Control Study of Non-Hodgkin’s Lymphoma https://ClinicalTrials.gov/show/NCT00341952 Completed National Institutes of Health Clinical Center (CC) NA
NCT00339638 Study of Adult T-Cell Leukemia/Lymphoma Among Carriers of HTLV-1 https://ClinicalTrials.gov/show/NCT00339638 Completed National Institutes of Health Clinical Center (CC) NA
NCT00301314 A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Hodgkin Lymphoma (HL). https://ClinicalTrials.gov/show/NCT00301314 Completed Royal Marsden NHS Foundation Trust NA
NCT00301301 A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL) https://ClinicalTrials.gov/show/NCT00301301 Completed Royal Marsden NHS Foundation Trust NA
NCT00301288 A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Non-Hodgkin Lymphoma (NHL). https://ClinicalTrials.gov/show/NCT00301288 Completed Royal Marsden NHS Foundation Trust NA
NCT00286832 Early On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma Stage IIB-IV https://ClinicalTrials.gov/show/NCT00286832 Completed Copenhagen University Hospital at Herlev 2011-01-31
NCT00281814 Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant https://ClinicalTrials.gov/show/NCT00281814 Completed The Cleveland Clinic 2008-12-31
NCT00281801 Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation https://ClinicalTrials.gov/show/NCT00281801 Completed Case Comprehensive Cancer Center 2008-12-31
NCT00240591 Patients With Low-Grade Non-Hodgkin’s Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 Tositumomab https://ClinicalTrials.gov/show/NCT00240591 Completed GlaxoSmithKline 2010-06-30
NCT00240578 Patients With Low-Grade Non-Hodgkin’s Lymphoma Previously Treated With Iodine I 131 Tositumomab https://ClinicalTrials.gov/show/NCT00240578 Completed GlaxoSmithKline 2013-06-30
NCT00226304 Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System Lymphoma https://ClinicalTrials.gov/show/NCT00226304 Completed National Institutes of Health Clinical Center (CC) NA
NCT00186147 Bone Marrow Grafting for Leukemia and Lymphoma https://ClinicalTrials.gov/show/NCT00186147 Enrolling by invitation Stanford University 2069-12-31
NCT00177268 Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research https://ClinicalTrials.gov/show/NCT00177268 Recruiting University of Pittsburgh 2027-01-31
NCT00177190 In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL) https://ClinicalTrials.gov/show/NCT00177190 Completed University of Pittsburgh 2005-01-31
NCT00126477 Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer https://ClinicalTrials.gov/show/NCT00126477 Completed Fred Hutchinson Cancer Research Center 2007-04-30
NCT00098566 Long-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin’s Lymphoma https://ClinicalTrials.gov/show/NCT00098566 Completed Fred Hutchinson Cancer Research Center 2011-06-30
NCT00097565 An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin’s Lymphoma https://ClinicalTrials.gov/show/NCT00097565 Completed Genentech, Inc. 2014-03-31
NCT00091091 Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin’s Lymphoma https://ClinicalTrials.gov/show/NCT00091091 Completed Children’s Oncology Group 2011-06-27
NCT00004875 Heparin or Enoxaparin in Patients With Cancer https://ClinicalTrials.gov/show/NCT00004875 Completed Northwestern University 1999-03-31
NCT00002563 SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin’s Disease https://ClinicalTrials.gov/show/NCT00002563 Completed Southwest Oncology Group 2003-09-30
NCT00006342 Genetic Study in Patients Receiving Treatment for Hodgkin’s Disease or Childhood Brain Tumor https://ClinicalTrials.gov/show/NCT00006342 Completed Duke University 2000-09-30
NCT00002485 Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer https://ClinicalTrials.gov/show/NCT00002485 Completed Children’s Oncology Group 2003-07-31
NCT00068146 Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma https://ClinicalTrials.gov/show/NCT00068146 Completed National Institutes of Health Clinical Center (CC) NA
NCT00003863 Diagnostic Study of Patients With Aggressive Non-Hodgkin’s Lymphoma https://ClinicalTrials.gov/show/NCT00003863 Completed Alliance for Clinical Trials in Oncology 2005-05-31
NCT00001301 Chronic and Late Effects of Non-Hodgkin’s Lymphoma and Its Treatment in Long Term Survivors https://ClinicalTrials.gov/show/NCT00001301 Completed National Institutes of Health Clinical Center (CC) NA
NCT00026910 Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin’s Lymphoma https://ClinicalTrials.gov/show/NCT00026910 Completed National Institutes of Health Clinical Center (CC) NA
NCT00005881 Quality of Life in Children Treated for Cancer https://ClinicalTrials.gov/show/NCT00005881 Completed Children’s Oncology Group 2003-03-31
NCT00754117 Early Response Assessment in Diffuse Large B-Cell Lymphoma (DLCL) Patients by 18-fluoro-2-deoxyglycose Positron Emission Tomography (FDG-PET) https://ClinicalTrials.gov/show/NCT00754117 Completed Weill Medical College of Cornell University 2010-12-31
NCT00626496 Family Study of Lymphoproliferative Disorders https://ClinicalTrials.gov/show/NCT00626496 Recruiting Mayo Clinic 2025-12-31
NCT00001571 A Pilot Study of Non-Hodgkin’s Lymphoma: Chemotherapy and Blood Levels of Organochlorines https://ClinicalTrials.gov/show/NCT00001571 Completed National Institutes of Health Clinical Center (CC) NA
NCT00006518 Specimen Collections From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer https://ClinicalTrials.gov/show/NCT00006518 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00001120 A Study of Patients With AIDS Syndrome https://ClinicalTrials.gov/show/NCT00001120 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00001582 Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer https://ClinicalTrials.gov/show/NCT00001582 Recruiting National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT04342117 Observational Trial of Real-World Treatment Utilization and Effectiveness of PI3K-inhibitors in CLL/SLL and FL https://ClinicalTrials.gov/show/NCT04342117 Recruiting Verastem, Inc. 2023-04-30
NCT00889798 Tumor Registry of Lymphatic Neoplasia https://ClinicalTrials.gov/show/NCT00889798 Completed iOMEDICO AG 2019-08-31
NCT03313271 China Lymphoma Patient Registry Study https://ClinicalTrials.gov/show/NCT03313271 Recruiting Peking University 2027-05-17
NCT03207789 T-cell Brazil: Prospective Collection of Data in T-cell Lymphomas Patients https://ClinicalTrials.gov/show/NCT03207789 Enrolling by invitation Grupo de Estudos Multicentricos em Onco-Hematologia 2017-06-01
NCT03199066 Non-Hodgkin Lymphoma - Observational Epidemiological and Clinical Study (NiHiL) https://ClinicalTrials.gov/show/NCT03199066 Recruiting Czech Lymphoma Study Group 2020-12-31
NCT03130582 High-dose Etoposide Could Discriminate Patients With Refractory/Relapsed Lymphoma Benefit From APBSCT https://ClinicalTrials.gov/show/NCT03130582 Completed Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 2014-12-31
NCT03131531 Bergamo Lymphoid Cancer Registry https://ClinicalTrials.gov/show/NCT03131531 Recruiting A.O. Ospedale Papa Giovanni XXIII 2027-03-23
NCT03117036 Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III https://ClinicalTrials.gov/show/NCT03117036 Recruiting Samsung Medical Center 2022-02-28
NCT02869542 Institut Paoli Calmettes Lymphoma Database https://ClinicalTrials.gov/show/NCT02869542 Recruiting Institut Paoli-Calmettes 2030-01-31
NCT02849912 Signal Detection in Monoclonal and New Agents in Lymphoma https://ClinicalTrials.gov/show/NCT02849912 Completed Centre Hospitalier Universitaire de Nice 2015-04-30
NCT02835911 Clinical Cohort of Lymphoma Patients in Malawi https://ClinicalTrials.gov/show/NCT02835911 Recruiting UNC Lineberger Comprehensive Cancer Center 2020-12-31
NCT02736357 The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study https://ClinicalTrials.gov/show/NCT02736357 Active, not recruiting Mayo Clinic 2026-08-31
NCT02732236 Marginal Zone Lymphoma Cohort in Korea https://ClinicalTrials.gov/show/NCT02732236 Recruiting Dong-A University Hospital 2020-02-29
NCT02691351 Intercontinental Cooperative Non-Hodgkin T-cell Lymphoma Prospective Registry Study https://ClinicalTrials.gov/show/NCT02691351 Active, not recruiting Samsung Medical Center 2020-12-31
NCT03715296 Lenalidomide Based Immunotherapy in the Treatment of DLBCL https://ClinicalTrials.gov/show/NCT03715296 Recruiting Ruijin Hospital 2020-09-15
NCT02474550 Multicenter Prospective Registry Study of Diffuse Large B Cell Lymphoma https://ClinicalTrials.gov/show/NCT02474550 Recruiting Ajou University School of Medicine 2018-12-31
NCT02296164 Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma https://ClinicalTrials.gov/show/NCT02296164 Completed Helsinn Therapeutics (U.S.), Inc 2018-10-17
NCT02265497 Brazilian Network for Lymphoma Registry https://ClinicalTrials.gov/show/NCT02265497 Recruiting Instituto Nacional de Cancer, Brazil 2018-12-31
NCT03869619 REal World Data in LYmphoma and Survival in Adults https://ClinicalTrials.gov/show/NCT03869619 Recruiting Hospices Civils de Lyon 2027-10-31
NCT01877109 Samsung Medical Center-Lymphoma Cohort Study-II https://ClinicalTrials.gov/show/NCT01877109 Completed Samsung Medical Center 2017-02-28
NCT04220970 Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry https://ClinicalTrials.gov/show/NCT04220970 Recruiting The Lymphoma Academic Research Organisation 2032-06-07
NCT04158128 The Clinical Implications of Immune Checkpoint Pathways in PCNSL https://ClinicalTrials.gov/show/NCT04158128 Recruiting National Taiwan University Hospital 2019-12-31
NCT04127916 Bendamustine Plus Rituximab for Mantle Cell Lymphoma: a Multicenter Retrospective Analysis(BR-MCL) https://ClinicalTrials.gov/show/NCT04127916 Recruiting Samsung Medical Center 2020-12-31
NCT04112238 ctDNA and Metabolites in CSF as Early Biomarkers of Secondary CNS Involvement in Diffuse Large B-cell Lymphoma https://ClinicalTrials.gov/show/NCT04112238 Recruiting Herlev Hospital 2023-06-30
NCT04094051 Observational Study of CLL/SLL Treatment and Ibrutinib Treatment of CLL/SLL in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT04094051 Recruiting The First Affiliated Hospital with Nanjing Medical University 2020-12-31
NCT04062877 Clinical Application of Liquid Biopsy for Precise Diagnosis and Prognosis in Lymphoma https://ClinicalTrials.gov/show/NCT04062877 Recruiting Zhongda Hospital 2020-06-30
NCT04069845 A Registry Study in Lymphoma Patients Treated With Liposomal Doxorubicin https://ClinicalTrials.gov/show/NCT04069845 Recruiting Ruijin Hospital 2020-08-30
NCT03971318 A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With LBL https://ClinicalTrials.gov/show/NCT03971318 Recruiting Sun Yat-sen University 2022-05-05
NCT03958916 Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With BL/DLBCL https://ClinicalTrials.gov/show/NCT03958916 Recruiting Sun Yat-sen University 2022-05-05
NCT03964480 Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma. https://ClinicalTrials.gov/show/NCT03964480 Recruiting Associazione Angela Serra per la ricerca sul cancro 2023-01-30
NCT03766516 Registry of BrentuximabVedotinin Patients With R/R Anaplastic Large Cell Lymphoma or Classical HL https://ClinicalTrials.gov/show/NCT03766516 Recruiting Samsung Medical Center 2020-06-30
NCT03646422 AEDV Registry of Primary Cutaneous Lymphoma https://ClinicalTrials.gov/show/NCT03646422 Recruiting Fundación Academia Española de Dermatología 2025-01-01
NCT03440788 Patient-reported and Clinical Outcomes in Adults With Relapsed or Refractory Hodgkin’s Lymphoma Receiving Brentuximab Vedotin https://ClinicalTrials.gov/show/NCT03440788 Recruiting Multinational Center for Quality of Life Research, Russia 2020-05-01
NCT03971305 A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With Systemic ALK(+) ALCL https://ClinicalTrials.gov/show/NCT03971305 Recruiting Sun Yat-sen University 2022-05-05